메뉴 건너뛰기




Volumn 19, Issue 13, 2012, Pages 1921-1945

Privileged structures - Dream or reality: Preferential organization of azanaphthalene scaffold

Author keywords

Azanaphthalene scaffold; Chemical spaces; Database mining; Fragment based design; Privileged motifs

Indexed keywords

AZANAPHTHALENE; BUCLIZINE; CANDESARTAN; CETIRIZINE; CHLOROQUINE; CYCLIZINE; DROPERIDOL; EMEDASTINE; ERGOMETRINE; ETODOLAC; FELODIPINE; HYDROXYZINE; IRBESARTAN; ISOQUINOLINE; MEBENDAZOLE; MEPACRINE; NALIDIXIC ACID; NATURAL PRODUCT; NICARDIPINE; NIFEDIPINE; NILVADIPINE; NORFLOXACIN; OMEPRAZOLE; OXOLINIC ACID; QUINIDINE; QUINOLINE; QUINOLINE DERIVATIVE; ROSOXACIN; UNCLASSIFIED DRUG; VALSARTAN; ZOLMITRIPTAN;

EID: 84860511321     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712800167356     Document Type: Article
Times cited : (60)

References (287)
  • 1
    • 36749073295 scopus 로고    scopus 로고
    • Privileged structures and analogue-based drug discovery
    • Fischer, J.; Ganellin, C.R., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim
    • Kubinyi, H. Privileged Structures and Analogue-Based Drug Discovery. In: Analogue-Based Drug Discovery; Fischer, J.; Ganellin, C.R., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, 2006; pp. 53-68.
    • (2006) Analogue-Based Drug Discovery , pp. 53-68
    • Kubinyi, H.1
  • 2
    • 79961000327 scopus 로고    scopus 로고
    • Ligand specificity, privileged substructures and protein druggability from fragment-based screening
    • Barelier, S.; Krimm, I. Ligand specificity, privileged substructures and protein druggability from fragment-based screening. Curr. Opin. Chem. Biol., 2011, 15, 469-474.
    • (2011) Curr. Opin. Chem. Biol. , vol.15 , pp. 469-474
    • Barelier, S.1    Krimm, I.2
  • 3
    • 54949134905 scopus 로고    scopus 로고
    • Chemical substructures that enrich for biological activity
    • Klekota, J.; Lundell, G. Chemical substructures that enrich for biological activity. Bioinformatics, 2008, 24, 2518-2525.
    • (2008) Bioinformatics , vol.24 , pp. 2518-2525
    • Klekota, J.1    Lundell, G.2
  • 4
    • 21244498671 scopus 로고    scopus 로고
    • The top pharmaceuticals that changed the world
    • Baum, R.M. The top pharmaceuticals that changed the world. Chem. Eng. News, 2005, 83, p 5.
    • (2005) Chem. Eng. News , vol.83 , pp. 5
    • Baum, R.M.1
  • 6
    • 84860510666 scopus 로고    scopus 로고
    • Further progress in chemotherapy of bacterial infections
    • Nobel Lecture, December 12, 1947; Elsevier Publishing Company: Amsterdam
    • Domagk, G. Further progress in chemotherapy of bacterial infections. In: Nobel Lectures, Physiology or Medicine 1922-1941, Nobel Lecture, December 12, 1947; Elsevier Publishing Company: Amsterdam, 1965; pp. 490-527.
    • Nobel Lectures, Physiology or Medicine 1922-1941 , vol.1965 , pp. 490-527
    • Domagk, G.1
  • 10
    • 34547265045 scopus 로고    scopus 로고
    • Properties and architecture of drugs and natural products revisited
    • Grabowski, K.; Schneider, G. Properties and architecture of drugs and natural products revisited. Curr. Chem. Biol., 2007, 1, 115-127.
    • (2007) Curr. Chem. Biol. , vol.1 , pp. 115-127
    • Grabowski, K.1    Schneider, G.2
  • 11
    • 0029894013 scopus 로고    scopus 로고
    • The properties of known drugs. 1. Molecular frameworks
    • DOI 10.1021/jm9602928
    • Bemis, G.W.; Murcko, M.A. The properties of known drugs. 1. Molecular frameworks. J. Med. Chem., 1996, 39, 2887-2893. (Pubitemid 26251026)
    • (1996) Journal of Medicinal Chemistry , vol.39 , Issue.15 , pp. 2887-2893
    • Bemis, G.W.1    Murcko, M.A.2
  • 12
    • 0033576605 scopus 로고    scopus 로고
    • Properties of known drugs. 2. Side chains
    • DOI 10.1021/jm9903996
    • Bemis, G.W.; Murcko, M.A. Properties of known drugs. 2. Side chains. J. Med. Chem., 1999, 42, 5095-5099. (Pubitemid 30020260)
    • (1999) Journal of Medicinal Chemistry , vol.42 , Issue.25 , pp. 5095-5099
    • Bemis, G.W.1    Murcko, M.A.2
  • 13
    • 77954331609 scopus 로고    scopus 로고
    • Scaffold explorer: An interactive tool for organizing and mining structure-activity data spanning multiple chemotypes
    • Agrafiotis, D.K.; Wiener, J.J. Scaffold explorer: an interactive tool for organizing and mining structure-activity data spanning multiple chemotypes. J. Med. Chem., 2010, 53, 5002-5011.
    • (2010) J. Med. Chem. , vol.53 , pp. 5002-5011
    • Agrafiotis, D.K.1    Wiener, J.J.2
  • 15
    • 68849110176 scopus 로고    scopus 로고
    • From nature to drug discovery: The indole scaffold as a "privileged structure"
    • de Sa Alves, F.R.; Barreiro, E.J.; Fraga, C.A.M. From nature to drug discovery: the indole scaffold as a "privileged structure". Mini Rev. Med. Chem., 2009, 9, 782-793.
    • (2009) Mini Rev. Med. Chem. , vol.9 , pp. 782-793
    • De Sa Alves, F.R.1    Barreiro, E.J.2    Fraga, C.A.M.3
  • 18
    • 11144320699 scopus 로고    scopus 로고
    • Navigating chemical space for biology and medicine
    • DOI 10.1038/nature03193
    • Lipinski, C.; Hopkins, A. Navigating chemical space for biology and medicine. Nature, 2004, 432, 855-861. (Pubitemid 40037141)
    • (2004) Nature , vol.432 , Issue.7019 , pp. 855-861
    • Lipinski, C.1    Hopkins, A.2
  • 19
    • 11144341956 scopus 로고    scopus 로고
    • Chemical space and biology
    • DOI 10.1038/nature03192
    • Dobson, C.M. Chemical space and biology. Nature, 2004, 7019, 824-828. (Pubitemid 40037137)
    • (2004) Nature , vol.432 , Issue.7019 , pp. 824-828
    • Dobson, C.M.1
  • 20
    • 0030039619 scopus 로고    scopus 로고
    • The art and practice of structure-based drug design: A molecular modeling perspective
    • DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6
    • Bohacek, R.S.; McMartin, C.; Guida, W.C. The art and practice of structurebased drug design: a molecular modeling perspective. Med. Res. Rev., 1996, 16, 3-50. (Pubitemid 26037075)
    • (1996) Medicinal Research Reviews , vol.16 , Issue.1 , pp. 3-50
    • Bohacek, R.S.1    McMartin, C.2    Guida, W.C.3
  • 21
    • 44949134801 scopus 로고    scopus 로고
    • The impact of natural products upon modern drug discovery
    • Ganesan, A. The impact of natural products upon modern drug discovery. Curr. Opin. Chem. Biol., 2008, 12, 306-317.
    • (2008) Curr. Opin. Chem. Biol. , vol.12 , pp. 306-317
    • Ganesan, A.1
  • 22
    • 0038042482 scopus 로고    scopus 로고
    • Chemical substructures in drug discovery
    • DOI 10.1016/S1359-6446(03)02740-5, PII S1359644603027405
    • Merlot, C.; Domine, D.; Cleva, C.; Church, D.J. Chemical substructures in drug discovery. Drug Discov. Today, 2003, 8, 594-602. (Pubitemid 36875723)
    • (2003) Drug Discovery Today , vol.8 , Issue.13 , pp. 594-602
    • Merlot, C.1    Domine, D.2    Cleva, C.3    Church, D.J.4
  • 23
    • 84870999598 scopus 로고    scopus 로고
    • Pyramid: An integrated platform for fragment-based drug discovery
    • Jahnke, W.; Erlanson, D.A., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim
    • Davies, T.G.; van Montfort, R.L.M.; Williams, G.; Jhoti, H. Pyramid: An Integrated Platform for Fragment-Based Drug Discovery. In: Fragment-Based Approaches in Drug Discovery; Jahnke, W.; Erlanson, D.A., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, 2006; pp. 193-214.
    • (2006) Fragment-Based Approaches in Drug Discovery , pp. 193-214
    • Davies, T.G.1    Van Montfort, R.L.M.2    Williams, G.3    Jhoti, H.4
  • 24
    • 0032572819 scopus 로고    scopus 로고
    • Can we learn to distinguish between 'drug-like' and 'nondrug-like' molecules?
    • DOI 10.1021/jm970666c
    • Ajay, A.; Walters, W.P.; Murcko, M.A. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? J. Med. Chem., 1998, 41, 3314-3324. (Pubitemid 28406538)
    • (1998) Journal of Medicinal Chemistry , vol.41 , Issue.18 , pp. 3314-3324
    • Ajay, A.1    Walters, W.P.2    Murcko, M.A.3
  • 25
    • 0032572816 scopus 로고    scopus 로고
    • A scoring scheme for discriminating between drugs and nondrugs
    • DOI 10.1021/jm9706776
    • Sadowski, J.; Kubinyi, H. A scoring scheme for discriminating between drugs and nondrugs. J. Med. Chem., 1998, 41, 3325-3329. (Pubitemid 28406539)
    • (1998) Journal of Medicinal Chemistry , vol.41 , Issue.18 , pp. 3325-3329
    • Sadowski, J.1    Kubinyi, H.2
  • 26
    • 0035289779 scopus 로고    scopus 로고
    • Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
    • DOI 10.1016/S0169-409X(00)00129-0, PII S0169409X00001290
    • Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 2001, 46, 3-26. (Pubitemid 33653411)
    • (2000) Advanced Drug Delivery Reviews , vol.46 , Issue.1-3 , pp. 3-26
    • Lipinski, C.A.1    Lombardo, F.2    Dominy, B.W.3    Feeney, P.J.4
  • 28
    • 79960239942 scopus 로고    scopus 로고
    • Definition of drug-likeness for compound affinity
    • Fukunishi, Y.; Nakamura, H. Definition of drug-likeness for compound affinity. J. Chem. Inf. Model., 2011, 51, 1012-1016.
    • (2011) J. Chem. Inf. Model. , vol.51 , pp. 1012-1016
    • Fukunishi, Y.1    Nakamura, H.2
  • 29
    • 77956028583 scopus 로고    scopus 로고
    • Model-free drug-likeness from fragments
    • Ursu, O.; Oprea, T.I. Model-free drug-likeness from fragments. J. Chem. Inf. Model., 2010, 50, 1387-1394.
    • (2010) J. Chem. Inf. Model. , vol.50 , pp. 1387-1394
    • Ursu, O.1    Oprea, T.I.2
  • 30
    • 2942564021 scopus 로고    scopus 로고
    • Pursuing the leadlikeness concept in pharmaceutical research
    • DOI 10.1016/j.cbpa.2004.04.003, PII S1367593104000493
    • Hann, M.M.; Oprea, T.I. Pursuing the leadlikeness concept in pharmaceutical research. Curr. Opin. Chem. Biol., 2004, 8, 255-263. (Pubitemid 38759400)
    • (2004) Current Opinion in Chemical Biology , vol.8 , Issue.3 , pp. 255-263
    • Hann, M.M.1    Oprea, T.I.2
  • 33
    • 46249123633 scopus 로고    scopus 로고
    • A maximum common substructure-based algorithm for searching and predicting drug-like compounds
    • DOI 10.1093/bioinformatics/btn186
    • Cao, Y.; Jiang, T.; Girke, T. A maximum common substructure-based algorithm for searching and predicting drug-like compounds. Bioinformatics, 2008, 24, i366-374. (Pubitemid 351911692)
    • (2008) Bioinformatics , vol.24 , Issue.13
    • Cao, Y.1    Jiang, T.2    Girke, T.3
  • 34
    • 41549115075 scopus 로고    scopus 로고
    • Assessing drug-likeness - What are we missing?
    • Vistoli, G.; Pedretti, A.; Testa, B. Assessing drug-likeness - what are we missing? Drug Discov. Today, 2008, 13, 285-294.
    • (2008) Drug Discov. Today , vol.13 , pp. 285-294
    • Vistoli, G.1    Pedretti, A.2    Testa, B.3
  • 36
    • 33845511093 scopus 로고    scopus 로고
    • Automatic and efficient decomposition of two-dimensional structures of small molecules for fragment-based high-throughput docking
    • DOI 10.1021/jm060838i
    • Kolb, P.; Caflisch, A. Automatic and efficient decomposition of twodimensional structures of small molecules for fragment-based highthroughput docking. J. Med. Chem., 2006, 49, 7384-7392. (Pubitemid 44913398)
    • (2006) Journal of Medicinal Chemistry , vol.49 , Issue.25 , pp. 7384-7392
    • Kolb, P.1    Caflisch, A.2
  • 37
    • 51849144627 scopus 로고    scopus 로고
    • Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery
    • Ghose, A.K.; Herbertz, T.; Pippin, D.A.; Salvino, J.M.; Mallamo, J.P. Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery. J. Med. Chem., 2008, 51, 5149-5171.
    • (2008) J. Med. Chem. , vol.51 , pp. 5149-5171
    • Ghose, A.K.1    Herbertz, T.2    Pippin, D.A.3    Salvino, J.M.4    Mallamo, J.P.5
  • 39
    • 78650633021 scopus 로고    scopus 로고
    • Computational medicinal chemistry in fragment-based drug discovery: What, how and when
    • Rabal, O.; Urbano-Cuadrado, M.; Oyarzabal, J. Computational medicinal chemistry in fragment-based drug discovery: what, how and when. Future Med. Chem., 2011, 3, 95-134.
    • (2011) Future Med. Chem. , vol.3 , pp. 95-134
    • Rabal, O.1    Urbano-Cuadrado, M.2    Oyarzabal, J.3
  • 41
    • 33646258711 scopus 로고    scopus 로고
    • Mining a chemical database for fragment co-occurrence: Discovery of "chemical clichés"
    • Lameijer, E.W.; Kok, J.N.; Back, T.; Ijzerman, A.P. Mining a chemical database for fragment co-occurrence: discovery of "chemical clichés". J. Chem. Inf. Model., 2006, 46, 553-562.
    • (2006) J. Chem. Inf. Model. , vol.46 , pp. 553-562
    • Lameijer, E.W.1    Kok, J.N.2    Back, T.3    Ijzerman, A.P.4
  • 42
    • 57549115967 scopus 로고    scopus 로고
    • Identification and selection of "privileged fragments" suitable for primary screening
    • Gianti, E.; Sartori, L. Identification and selection of "privileged fragments" suitable for primary screening. J. Chem. Inf. Model., 2008, 48, 2129-2139.
    • (2008) J. Chem. Inf. Model. , vol.48 , pp. 2129-2139
    • Gianti, E.1    Sartori, L.2
  • 43
    • 0032058905 scopus 로고    scopus 로고
    • RECAP - Retrosynthetic Combinatorial Analysis Procedure: A powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry
    • Lewell, X.Q.; Judd, D.B.; Watson, S.P.; Hann, M.M. RECAP - retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J. Chem. Inf. Comput. Sci., 1998, 38, 511-522. (Pubitemid 128594467)
    • (1998) Journal of Chemical Information and Computer Sciences , vol.38 , Issue.3 , pp. 511-522
    • Lewell, X.Q.1    Judd, D.B.2    Watson, S.P.3    Hann, M.M.4
  • 44
    • 70249139317 scopus 로고    scopus 로고
    • Receptor dependent multidimensional QSAR for modeling drugreceptor interactions
    • Polanski, J. Receptor dependent multidimensional QSAR for modeling drugreceptor interactions. Curr. Med. Chem., 2009, 16, 3243-3257.
    • (2009) Curr. Med. Chem. , vol.16 , pp. 3243-3257
    • Polanski, J.1
  • 46
    • 84859906267 scopus 로고    scopus 로고
    • Recent advances in development, validation and exploitation of QSAR models
    • John Wiley & Sons
    • Tropsha, A. Recent Advances in Development, Validation and Exploitation of QSAR Models. In: Burger's Medicinal Chemistry, Drug Discovery and Development; John Wiley & Sons, 2010; pp. 1-30.
    • (2010) Burger's Medicinal Chemistry, Drug Discovery and Development , pp. 1-30
    • Tropsha, A.1
  • 47
    • 0001376170 scopus 로고    scopus 로고
    • Potential drugs and nondrugs: Prediction and identification of important structural features
    • Wagener, M.; van Geerestein, V.J. Potential drugs and nondrugs: prediction and identification of important structural features. J. Chem. Inf. Comput. Sci., 2000, 40, 280-292.
    • (2000) J. Chem. Inf. Comput. Sci. , vol.40 , pp. 280-292
    • Wagener, M.1    Van Geerestein, V.J.2
  • 48
    • 78650699097 scopus 로고    scopus 로고
    • Molecular topology analysis of the differences between drugs, clinical candidate compounds, and bioactive molecules
    • Chen, H.; Yang, Y.; Engkvist, O. Molecular topology analysis of the differences between drugs, clinical candidate compounds, and bioactive molecules. J. Chem. Inf. Model., 2010, 50, 2141-2150.
    • (2010) J. Chem. Inf. Model. , vol.50 , pp. 2141-2150
    • Chen, H.1    Yang, Y.2    Engkvist, O.3
  • 49
    • 0034073605 scopus 로고    scopus 로고
    • Property distribution of drug-related chemical databases
    • DOI 10.1023/A:1008130001697
    • Oprea, T.I. Property distribution of drug-related chemical databases. J. Comput. Aided Mol. Des., 2000, 14, 251-264. (Pubitemid 30175944)
    • (2000) Journal of Computer-Aided Molecular Design , vol.14 , Issue.3 , pp. 251-264
    • Oprea, T.I.1
  • 50
    • 33751313329 scopus 로고    scopus 로고
    • Knowledge-based chemoinformatic approaches to drug discovery
    • DOI 10.1016/j.drudis.2006.10.012, PII S1359644606004338
    • Ghose, A.K.; Herbertz, T.; Salvino, J.M.; Mallamo, J.P. Knowledge-based chemoinformatic approaches to drug discovery. Drug Discov. Today, 2006, 11, 1107-1114. (Pubitemid 44803112)
    • (2006) Drug Discovery Today , vol.11 , Issue.23-24 , pp. 1107-1114
    • Ghose, A.K.1    Herbertz, T.2    Salvino, J.M.3    Mallamo, J.P.4
  • 51
    • 35748934487 scopus 로고    scopus 로고
    • The influence of drug-like concepts on decision-making in medicinal chemistry
    • DOI 10.1038/nrd2445, PII NRD2445
    • Leeson, P.D.; Springthorpe, B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nat. Rev. Drug Discov., 2007, 6, 881-890. (Pubitemid 350042396)
    • (2007) Nature Reviews Drug Discovery , vol.6 , Issue.11 , pp. 881-890
    • Leeson, P.D.1    Springthorpe, B.2
  • 52
    • 33644872086 scopus 로고    scopus 로고
    • Privileged structures as leads in medicinal chemistry
    • Costantino, L.; Barlocco, D. Privileged structures as leads in medicinal chemistry. Curr. Med. Chem., 2006, 13, 65-85.
    • (2006) Curr. Med. Chem. , vol.13 , pp. 65-85
    • Costantino, L.1    Barlocco, D.2
  • 53
    • 60549099994 scopus 로고    scopus 로고
    • Detection and assignment of common scaffolds in project databases of lead molecules
    • Clark, A.M.; Labute, P. Detection and assignment of common scaffolds in project databases of lead molecules. J. Med. Chem., 2009, 52, 469-483.
    • (2009) J. Med. Chem. , vol.52 , pp. 469-483
    • Clark, A.M.1    Labute, P.2
  • 54
    • 70349425790 scopus 로고    scopus 로고
    • Recent progress in fragment-based lead discovery
    • Schulz, M.N.; Hubbard, R.E. Recent progress in fragment-based lead discovery. Curr. Opin. Pharmacol., 2009, 9, 615-621.
    • (2009) Curr. Opin. Pharmacol. , vol.9 , pp. 615-621
    • Schulz, M.N.1    Hubbard, R.E.2
  • 55
    • 36749018204 scopus 로고    scopus 로고
    • Privileged structures: A useful concept for the rational design of new lead drug candidates
    • DOI 10.2174/138955707782331722
    • Duarte, C.D.; Barreiro, E.J.; Fraga, C.A.M. Privileged structures: a useful concept for the rational design of new lead drug candidates. Mini Rev. Med. Chem., 2007, 7, 1108-1119. (Pubitemid 350200217)
    • (2007) Mini-Reviews in Medicinal Chemistry , vol.7 , Issue.11 , pp. 1108-1119
    • Duarte, C.D.1    Barreiro, E.J.2    Fraga, C.A.M.3
  • 56
    • 0036589285 scopus 로고    scopus 로고
    • Current trends in lead discovery: Are we looking for the appropriate properties?
    • DOI 10.1023/A:1020877402759
    • Oprea, T.I. Current trends in lead discovery: are we looking for the appropriate properties? J. Comput. Aided Mol. Des., 2002, 16, 325-334. (Pubitemid 35414666)
    • (2002) Journal of Computer-Aided Molecular Design , vol.16 , Issue.5-6 , pp. 325-334
    • Oprea, T.I.1
  • 58
    • 1242271305 scopus 로고    scopus 로고
    • Molecular recognition: The fragment approach in lead generation
    • DOI 10.1016/S1359-6446(03)03007-1, PII S1359644603030071
    • Fattori, D. Molecular recognition: the fragment approach in lead generation. Drug Discov. Today, 2004, 9, 229-238. (Pubitemid 38230022)
    • (2004) Drug Discovery Today , vol.9 , Issue.5 , pp. 229-238
    • Fattori, D.1
  • 59
    • 2942702317 scopus 로고    scopus 로고
    • SVM-based feature selection for characterization of focused compound collections
    • Byvatov, E.; Schneider, G.J. SVM-based feature selection for characterization of focused compound collections. J. Chem. Inf. Comput. Sci., 2004, 44, 993-999.
    • (2004) J. Chem. Inf. Comput. Sci. , vol.44 , pp. 993-999
    • Byvatov, E.1    Schneider, G.J.2
  • 60
    • 19944391612 scopus 로고    scopus 로고
    • Target-related Affinity Profiling: Telik's lead discovery technology
    • DOI 10.2174/1568026053828394
    • Beroza, P.; Damodaran, K.; Lum, R.T. Target-related affinity profiling: Telik's lead discovery technology. Curr. Top. Med. Chem., 2005, 5, 371-381. (Pubitemid 40753874)
    • (2005) Current Topics in Medicinal Chemistry , vol.5 , Issue.4 , pp. 371-381
    • Beroza, P.1    Damodaran, K.2    Lum, R.T.3
  • 62
    • 0036214750 scopus 로고    scopus 로고
    • Virtual screening in drug discovery: Methods, expectations and reality
    • Bajorath, J. Virtual screening: methods, expectations and reality. Curr. Drug Discov., 2002, 2, 24-28. (Pubitemid 34269451)
    • (2002) Current Drug Discovery , Issue.MAR. , pp. 24-28
    • Bajorath, J.1
  • 63
    • 0036835460 scopus 로고    scopus 로고
    • Integration of virtual and high-throughput screening
    • DOI 10.1038/nrd941
    • Bajorath, J. Integration of virtual and high-throughput screening. Nat. Rev. Drug Discov., 2002, 1, 882-894. (Pubitemid 37361583)
    • (2002) Nature Reviews Drug Discovery , vol.1 , Issue.11 , pp. 882-894
    • Bajorath, J.1
  • 64
    • 0036980746 scopus 로고    scopus 로고
    • Chemical similarity and biological activities
    • Kubinyi, H. Chemical similarity and biological activities. J. Braz. Chem. Soc., 2002, 13, 717-726. (Pubitemid 36181535)
    • (2002) Journal of the Brazilian Chemical Society , vol.13 , Issue.6 , pp. 717-726
    • Kubinyi, H.1
  • 65
    • 34249085274 scopus 로고    scopus 로고
    • How can structural similarity analysis help in category formation?
    • DOI 10.1080/10629360701306050, PII 778871248
    • Jaworska, J.; Nikolova-Jeliazkova, N. How can structural similarity analysis help in category formation? SAR QSAR Environ. Res., 2007, 18, 195-207. (Pubitemid 46789491)
    • (2007) SAR and QSAR in Environmental Research , vol.18 , Issue.3-4 , pp. 195-207
    • Jaworska, J.1    Nikolova-Jeliazkova, N.2
  • 68
    • 33645422011 scopus 로고    scopus 로고
    • Are target-family-privileged substructures truly privileged?
    • Schnur, D.M.; Hermsmeier, M.A.; Tebben, A.J. Are target-family-privileged substructures truly privileged? J. Med. Chem., 2006, 49, 2000-2009.
    • (2006) J. Med. Chem. , vol.49 , pp. 2000-2009
    • Schnur, D.M.1    Hermsmeier, M.A.2    Tebben, A.J.3
  • 69
    • 65249109527 scopus 로고    scopus 로고
    • Molecular substructure mining approaches for computer-aided drug discovery: A review
    • Ioannina Greece October
    • Nicolaou, C.A.; Pattichis, C.S. Molecular Substructure Mining Approaches for Computer-Aided Drug Discovery: A Review. In: Proceedings of ITAB; Ioannina, Greece, October 26-28, 2006.
    • (2006) Proceedings of ITAB , pp. 26-28
    • Nicolaou, C.A.1    Pattichis, C.S.2
  • 71
    • 0037366605 scopus 로고    scopus 로고
    • The combinatorial synthesis of bicyclic privileged structures or privileged substructures
    • Horton, D.A.; Bourne, G.T.; Smythe, M.L. The combinatorial synthesis of bicyclic privileged structures or privileged substructures. Chem. Rev., 2003, 103, 893-930.
    • (2003) Chem. Rev. , vol.103 , pp. 893-930
    • Horton, D.A.1    Bourne, G.T.2    Smythe, M.L.3
  • 72
    • 39049124587 scopus 로고    scopus 로고
    • Privileged scaffolds targeting reverse-turn and helix recognition
    • DOI 10.1517/14728222.12.1.101
    • Che, Y.; Marshall, G.R. Privileged scaffolds targeting reverse-turn and helix recognition. Expert Opin. Ther. Targets, 2008, 12, 101-114. (Pubitemid 351247166)
    • (2008) Expert Opinion on Therapeutic Targets , vol.12 , Issue.1 , pp. 101-114
    • Che, Y.1    Marshall, G.R.2
  • 73
    • 0037138701 scopus 로고    scopus 로고
    • Enantioselective organocatalytic indole alkylations. Design of a new and highly effective chiral amine for iminium catalysis
    • DOI 10.1021/ja017255c
    • Austin, J.F.; MacMillan, D.W.C. Enantioselective organocatalytic indole alkylations. Design of a new and highly effective chiral amine for iminium catalysis. J. Am. Chem. Soc., 2002, 124, 1172-1173. (Pubitemid 34169116)
    • (2002) Journal of the American Chemical Society , vol.124 , Issue.7 , pp. 1172-1173
    • Austin, J.F.1    MacMillan, D.W.C.2
  • 74
    • 0034618541 scopus 로고    scopus 로고
    • Privileged molecules for protein binding identified from NMR-based screening
    • Hajduk, P.J.; Bures, M.; Praestgaard, J.; Fesik, S.W. Privileged molecules for protein binding identified from NMR-based screening. J. Med. Chem., 2000, 43, 3443-3447.
    • (2000) J. Med. Chem. , vol.43 , pp. 3443-3447
    • Hajduk, P.J.1    Bures, M.2    Praestgaard, J.3    Fesik, S.W.4
  • 76
    • 0034601292 scopus 로고    scopus 로고
    • 2 receptors
    • DOI 10.1016/S0165-1838(00)00128-4, PII S0165183800001284
    • Jacobson, K.A.; Kim, Y.C.; King, B.F. In search of selective P2 receptor ligands: interaction of dihydropyridine derivatives at recombinant rat P2X(2) receptors. J. Auton. Nerv. Syst., 2000, 81, 152-157. (Pubitemid 30408492)
    • (2000) Journal of the Autonomic Nervous System , vol.81 , Issue.1-3 , pp. 152-157
    • Jacobson, K.A.1    Kim, Y.-C.2    King, B.F.3
  • 77
    • 0035874704 scopus 로고    scopus 로고
    • 2,6-Dichloro-9-thiabicyclo[3.3.1]nonane: A privileged, bivalent scaffold for the display of nucleophilic components
    • DOI 10.1021/jo015632y
    • Converso, A.; Burow, K.; Marzinzik, A.; Sharpless, K.B.; Finn, M.G. 2,6-Dichloro-9-thiabicyclo[3.3.1]nonane: a privileged bivalent scaffold for the display of nucleophilic components. J. Org. Chem., 2001, 66, 4386-4392. (Pubitemid 32867583)
    • (2001) Journal of Organic Chemistry , vol.66 , Issue.12 , pp. 4386-4392
    • Converso, A.1    Burow, K.2    Marzinzik, A.3    Sharpless, K.B.4    Finn, M.G.5
  • 78
    • 0034684250 scopus 로고    scopus 로고
    • Natural product-like combinatorial libraries based on privileged structures. 1. General principles and solid-phase synthesis of benzopyrans
    • Nicolaou, K.C.; Pfefferkorn, J.A.; Roecker, A.J.; Cao, G.Q.; Barluenga, S.; Mitchell, H.J. Natural product-like combinatorial libraries based on privileged structures. 1. General principles and solid-phase synthesis of benzopyrans. J. Am. Chem. Soc., 2000, 122, 9939-9953.
    • (2000) J. Am. Chem. Soc. , vol.122 , pp. 9939-9953
    • Nicolaou, K.C.1    Pfefferkorn, J.A.2    Roecker, A.J.3    Cao, G.Q.4    Barluenga, S.5    Mitchell, H.J.6
  • 79
    • 0035382954 scopus 로고    scopus 로고
    • Discovery of novel antibacterial agents active against methicillin-resistant Staphylococcus aureus from combinatorial benzopyran libraries
    • Nicolaou, K.C.; Roecker, A.J.; Barluenga, S.; Pfefferkorn, J.A.; Cao, G.Q. Discovery of novel antibacterial agents active against methicillin- resistant Staphylococcus aureus from combinatorial benzopyran libraries. Chembiochem, 2001, 2, 460-465. (Pubitemid 33723578)
    • (2001) ChemBioChem , vol.2 , Issue.6 , pp. 460-465
    • Nicolaou, K.C.1    Roecker, A.J.2    Barluenga, S.3    Pfefferkorn, J.A.4    Cao, G.-Q.5
  • 80
    • 80053601542 scopus 로고    scopus 로고
    • Are pyridazines privileged structures?
    • Wermuth, C.G. Are pyridazines privileged structures? Medchemcomm, 2011, 2, 935-941.
    • (2011) Medchemcomm , vol.2 , pp. 935-941
    • Wermuth, C.G.1
  • 82
    • 79955004745 scopus 로고    scopus 로고
    • Quinoline as a privileged scaffold in cancer drug discovery
    • Solomon, V.R.; Lee, H. Quinoline as a privileged scaffold in cancer drug discovery. Curr. Med. Chem., 2011, 18, 1488-1508.
    • (2011) Curr. Med. Chem. , vol.18 , pp. 1488-1508
    • Solomon, V.R.1    Lee, H.2
  • 83
    • 0028151607 scopus 로고
    • Nilvadipine: Profile of a new calcium antagonist. An overview
    • Rosenthal, J. Nilvadipine: profile of a new calcium antagonist. An overview. J. Cardiovasc. Pharmacol., 1994, 24 Suppl 2, S92-107. (Pubitemid 24369890)
    • (1994) Journal of Cardiovascular Pharmacology , vol.24 , Issue.SUPPL. 2
    • Rosenthal, J.1
  • 84
    • 84862904241 scopus 로고    scopus 로고
    • Intravenous Diazepam Midazolam and Lorazepam in acute seizure control
    • Epub ahead of print
    • Gathwala, G.; Goel, M.; Singh, J.; Mittal, K. Intravenous Diazepam, Midazolam and Lorazepam in acute seizure control. Indian J. Pediatr., 2011, Epub ahead of print.
    • (2011) Indian J. Pediatr.
    • Gathwala, G.1    Goel, M.2    Singh, J.3    Mittal, K.4
  • 85
    • 0031690854 scopus 로고    scopus 로고
    • Anticonvulsant properties of 1,4-benzodiazepine derivatives in amygdaloid-kindled seizures and their chemical structure-related anticonvulsant action
    • DOI 10.1159/000028247
    • Fukinaga, M.; Ishizawa, K.; Kamei, C. Anticonvulsant properties of 1,4-benzodiazepine derivatives in amygdaloid-kindled seizures and their chemical structure-related anticonvulsant action. Pharmacology, 1998, 57, 233-241. (Pubitemid 28444865)
    • (1998) Pharmacology , vol.57 , Issue.5 , pp. 233-241
    • Fukinaga, M.1    Ishizawa, K.2    Kamei, C.3
  • 87
    • 79957574695 scopus 로고    scopus 로고
    • Buclizine is back again! This time as a pediatric appetite stimulant
    • Babu, T.A. Buclizine is back again! This time as a pediatric appetite stimulant. Indian J. Pharmacol., 2011, 43, 219.
    • (2011) Indian J. Pharmacol. , vol.43 , pp. 219
    • Babu, T.A.1
  • 89
    • 80054917722 scopus 로고    scopus 로고
    • Efficacy of second-generation antihistamines in patients with allergic rhinitis and comorbid asthma
    • Bachert, C.; Maspero, J. Efficacy of second-generation antihistamines in patients with allergic rhinitis and comorbid asthma. J. Asthma, 2011, 48, 965-973.
    • (2011) J. Asthma , vol.48 , pp. 965-973
    • Bachert, C.1    Maspero, J.2
  • 90
    • 39049173610 scopus 로고    scopus 로고
    • Nifedipine: A novel vasodilator
    • Taira, N. Nifedipine: a novel vasodilator. Drugs, 2006, 66, 1-3.
    • (2006) Drugs , vol.66 , pp. 1-3
    • Taira, N.1
  • 91
    • 39049097320 scopus 로고    scopus 로고
    • Antihypertensive effects of nifedipine and changing for modified-release formula
    • Kuwajima, I. Antihypertensive effects of nifedipine and changing for modified-release formula. Drugs, 2006, 66, 7-9.
    • (2006) Drugs , vol.66 , pp. 7-9
    • Kuwajima, I.1
  • 92
    • 84860542224 scopus 로고    scopus 로고
    • A systematic review of nicardipine vs labetalol for the management of hypertensive crises
    • Epub ahead of print
    • Peacock, W.F.; Hilleman, D.E.; Levy, P.D.; Rhoney, D.H.; Varon, J. A systematic review of nicardipine vs labetalol for the management of hypertensive crises. Am. J. Emerg. Med., 2011, Epub ahead of print.
    • (2011) Am. J. Emerg. Med.
    • Peacock, W.F.1    Hilleman, D.E.2    Levy, P.D.3    Rhoney, D.H.4    Varon, J.5
  • 93
    • 37549010689 scopus 로고    scopus 로고
    • Effect of nilvadipine on regional cerebral blood flow in a patient with early Alzheimer disease
    • Matsuda, H.; Araki, N.; Kuji, I.; Ohkubo, T.; Imabayashi, E.; Shimazu, K. Effect of nilvadipine on regional cerebral blood flow in a patient with early Alzheimer disease. Clin. Nucl. Med., 2008, 33, 34-35.
    • (2008) Clin. Nucl. Med. , vol.33 , pp. 34-35
    • Matsuda, H.1    Araki, N.2    Kuji, I.3    Ohkubo, T.4    Imabayashi, E.5    Shimazu, K.6
  • 94
    • 0028791005 scopus 로고
    • The evolving role of calcium channel blockers in the treatment of angina pectoris: Focus on felodipine
    • Gradman, A.H. The evolving role of calcium channel blockers in the treatment of angina pectoris: focus on felodipine. Can. J. Cardiol., 1995, 11 Suppl B, 14B-21B.
    • (1995) Can. J. Cardiol. , vol.11 SUPPL. B
    • Gradman, A.H.1
  • 95
    • 80555125035 scopus 로고    scopus 로고
    • Application of AT1-angiotensin II receptor blocker valsartan in clinical practice
    • Maksimov, M.L.; Mochkin, I.A.; Starodubtsev, A.K. Application of AT1-angiotensin II receptor blocker valsartan in clinical practice. Kardiologiia, 2011, 51, 77-84.
    • (2011) Kardiologiia , vol.51 , pp. 77-84
    • Maksimov, M.L.1    Mochkin, I.A.2    Starodubtsev, A.K.3
  • 96
    • 79952774764 scopus 로고    scopus 로고
    • Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals
    • Collaboration, T.A.T. Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals. J. Hypertens., 2011, 29, 623-635.
    • (2011) J. Hypertens. , vol.29 , pp. 623-635
    • Collaboration, T.A.T.1
  • 98
    • 84855466015 scopus 로고    scopus 로고
    • Droperidol for treatment of nausea and vomiting in palliative care patients
    • Dorman, S.; Perkins, P. Droperidol for treatment of nausea and vomiting in palliative care patients. Cochrane Database Syst. Rev., 2010, 6, CD006938.
    • (2010) Cochrane Database Syst. Rev. , vol.6
    • Dorman, S.1    Perkins, P.2
  • 100
    • 68149181539 scopus 로고    scopus 로고
    • Emedastine difumarate: A review of its potential ameliorating effect for tissue remodeling in allergic diseases
    • Murota, H.; Katayama, I. Emedastine difumarate: a review of its potential ameliorating effect for tissue remodeling in allergic diseases. Expert Opin. Pharmacother., 2009, 10, 1859-1867.
    • (2009) Expert Opin. Pharmacother. , vol.10 , pp. 1859-1867
    • Murota, H.1    Katayama, I.2
  • 101
    • 0035987755 scopus 로고    scopus 로고
    • Review of zolmitriptan and its clinical applications in migraine
    • DOI 10.1517/14656566.3.7.993
    • Dowson, A.J.; Charlesworth, B. Review of zolmitriptan and its clinical applications in migraine. Expert Opin. Pharmacother., 2002, 3, 993-1005. (Pubitemid 34752516)
    • (2002) Expert Opinion on Pharmacotherapy , vol.3 , Issue.7 , pp. 993-1005
    • Dowson, A.J.1    Charlesworth, B.2
  • 102
    • 0031043628 scopus 로고    scopus 로고
    • Tissue selective inhibition of prostaglandin biosynthesis by etodolac
    • Dvornik, D.M. Tissue selective inhibition of prostaglandin biosynthesis by etodolac. J. Rheumatol. Suppl., 1997, 47, 40-47.
    • (1997) J. Rheumatol. Suppl. , vol.47 , pp. 40-47
    • Dvornik, D.M.1
  • 103
    • 80052664727 scopus 로고    scopus 로고
    • Effect of ergot alkaloids on contractility of bovine right ruminal artery and vein
    • Foote, A.P.; Harmon, D.L.; Strickland, J.R.; Bush, L.P.; Klotz, J.L. Effect of ergot alkaloids on contractility of bovine right ruminal artery and vein. J. Anim. Sci., 2011, 89, 2944-2949.
    • (2011) J. Anim. Sci. , vol.89 , pp. 2944-2949
    • Foote, A.P.1    Harmon, D.L.2    Strickland, J.R.3    Bush, L.P.4    Klotz, J.L.5
  • 104
    • 79952217204 scopus 로고    scopus 로고
    • The concept of privileged structures in rational drug design: Focus on acridine and quinoline scaffolds in neurodegenerative and protozoan diseases
    • Bongarzone, S.; Bolognesi, M.L. The concept of privileged structures in rational drug design: focus on acridine and quinoline scaffolds in neurodegenerative and protozoan diseases. Expert Opin. Drug Discov., 2011, 6, 251-268.
    • (2011) Expert Opin. Drug Discov. , vol.6 , pp. 251-268
    • Bongarzone, S.1    Bolognesi, M.L.2
  • 106
    • 47349102980 scopus 로고    scopus 로고
    • Synthesis and pharmacological investigation of novel 2-aminothiazole- privileged aporphines
    • Liu, Z.; Chen, X.; Yu, L.; Zhen, X.; Zhang, A. Synthesis and pharmacological investigation of novel 2-aminothiazole-privileged aporphines. Bioorg. Med. Chem., 2008, 16, 6675-6681.
    • (2008) Bioorg. Med. Chem. , vol.16 , pp. 6675-6681
    • Liu, Z.1    Chen, X.2    Yu, L.3    Zhen, X.4    Zhang, A.5
  • 107
  • 110
    • 67651099103 scopus 로고    scopus 로고
    • Combinatorial library synthesis and biological evaluation of pyrazolo[4,3-e][1,4]diazepine as a potential privileged structure
    • Lee, J.Y.; Kim, Y.C. Combinatorial library synthesis and biological evaluation of pyrazolo[4,3-e][1,4]diazepine as a potential privileged structure. ChemMedChem, 2009, 4, 733-737.
    • (2009) ChemMedChem , vol.4 , pp. 733-737
    • Lee, J.Y.1    Kim, Y.C.2
  • 111
    • 33845736461 scopus 로고    scopus 로고
    • Drugs in other drugs: A new look at drugs as fragments
    • DOI 10.1016/j.drudis.2006.11.011, PII S1359644606004727
    • Siegel, M.G.; Vieth, M. Drugs in other drugs: a new look at drugs as fragments. Drug Discov. Today, 2007, 12, 71-79. (Pubitemid 46014488)
    • (2007) Drug Discovery Today , vol.12 , Issue.1-2 , pp. 71-79
    • Siegel, M.G.1    Vieth, M.2
  • 112
    • 0037374498 scopus 로고    scopus 로고
    • The price of innovation: New estimates of drug development costs
    • DOI 10.1016/S0167-6296(02)00126-1
    • DiMasi, J.A.; Hansen, R.W.; Grabowski, H.G. The price of innovation: new estimates of drug developments costs. J. Health Econ., 2003, 22, 151-185. (Pubitemid 36279392)
    • (2003) Journal of Health Economics , vol.22 , Issue.2 , pp. 151-185
    • DiMasi, J.A.1    Hansen, R.W.2    Grabowski, H.G.3
  • 114
    • 0031473381 scopus 로고    scopus 로고
    • Are me-too drugs justified?
    • Garattini, S. Are me-too drugs justified? J. Nephrol., 1997, 10, 283-294. (Pubitemid 28010023)
    • (1997) Journal of Nephrology , vol.10 , Issue.6 , pp. 283-294
    • Garattini, S.1
  • 115
    • 33847381100 scopus 로고    scopus 로고
    • A decade of fragment-based drug design: Strategic advances and lessons learned
    • DOI 10.1038/nrd2220, PII NRD2220
    • Hajduk, P.J.; Greer, J. A decade of fragment-based drug design: strategic advances and lessons learned. Nat. Rev. Drug Discov., 2007, 6, 211-219. (Pubitemid 46344625)
    • (2007) Nature Reviews Drug Discovery , vol.6 , Issue.3 , pp. 211-219
    • Hajduk, P.J.1    Greer, J.2
  • 116
    • 80051798254 scopus 로고    scopus 로고
    • Fragment-based lead discovery: Challenges and opportunities
    • Sun, C.; Petros, A.M.; Hajduk, P.J. Fragment-based lead discovery: challenges and opportunities. J. Comput. Aided Mol. Des., 2011, 25, 607-610.
    • (2011) J. Comput. Aided Mol. Des. , vol.25 , pp. 607-610
    • Sun, C.1    Petros, A.M.2    Hajduk, P.J.3
  • 118
    • 0035324944 scopus 로고    scopus 로고
    • Molecular complexity and its impact on the probability of finding leads for drug discovery
    • Hann, M.M.; Leach, A.R.; Harper, G. Molecular complexity and its impact on the probability of finding leads for drug discovery. J. Chem. Inf. Comput. Sci., 2001, 41, 856-864.
    • (2001) J. Chem. Inf. Comput. Sci. , vol.41 , pp. 856-864
    • Hann, M.M.1    Leach, A.R.2    Harper, G.3
  • 122
    • 0001611960 scopus 로고    scopus 로고
    • Neural nets for the simulation of molecular recognition within MS-windows environment
    • Polanski, J. Neural nets for the simulation of molecular recognition within MS-Windows environment. J. Chem. Inf. Comput. Sci., 1996, 36, 694-705. (Pubitemid 126581719)
    • (1996) Journal of Chemical Information and Computer Sciences , vol.36 , Issue.4 , pp. 694-705
    • Polanski, J.1
  • 123
    • 0031138166 scopus 로고    scopus 로고
    • The receptor-like neural network for modeling corticosteroid and testosterone binding globulins
    • Polanski, J. The receptor-like neural network for modeling corticosteroid and testosterone binding globulins. J. Chem. Inf. Comput. Sci., 1997, 37, 553-561. (Pubitemid 127603565)
    • (1997) Journal of Chemical Information and Computer Sciences , vol.37 , Issue.3 , pp. 553-561
    • Polanski, J.1
  • 124
    • 0021529312 scopus 로고
    • Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules
    • DOI 10.1021/ja00336a004
    • Klopman, G. Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules. J. Am. Chem. Soc., 1984, 106, 7315-7321. (Pubitemid 15216948)
    • (1984) Journal of the American Chemical Society , vol.106 , Issue.24 , pp. 7315-7321
    • Klopman, G.1
  • 125
    • 0022644866 scopus 로고
    • Quantitative structure-activity relationships of beta-adrenergic agents. Application of the computer automated structure evaluation (CASE) technique of molecular fragment recognition
    • DOI 10.1016/S0022-5193(86)80134-5
    • Klopman, G.; Kalos, A.N. Quantitative structure-activity relationships of beta-adrenergic agents. Application of the computer automated structure evaluation (CASE) technique of molecular fragment recognition. J. Theor. Biol., 1986, 118, 199-214. (Pubitemid 16190411)
    • (1986) Journal of Theoretical Biology , vol.118 , Issue.2 , pp. 199-214
    • Klopman, G.1    Kalos, A.N.2
  • 126
    • 84860530251 scopus 로고
    • Computer automated structure evaluation (CASE) of flavonoids as larval growth inhibitors
    • Klopman, G.; Venegas, R.E. Computer automated structure evaluation (CASE) of flavonoids as larval growth inhibitors. Pure Appl. Chem., 1988, 60, 265-270.
    • (1988) Pure Appl. Chem. , vol.60 , pp. 265-270
    • Klopman, G.1    Venegas, R.E.2
  • 127
    • 42949088496 scopus 로고    scopus 로고
    • Chemical fragments as foundations for understanding target space and activity prediction
    • DOI 10.1021/jm701399f
    • Sutherland, J.J.; Higgs, R.E.; Watson, I.; Vieth, M. Chemical fragments as foundations for understanding target space and activity prediction. J. Med. Chem., 2008, 51, 2689-2700. (Pubitemid 351620791)
    • (2008) Journal of Medicinal Chemistry , vol.51 , Issue.9 , pp. 2689-2700
    • Sutherland, J.J.1    Higgs, R.E.2    Watson, I.3    Vieth, M.4
  • 128
    • 65249092242 scopus 로고    scopus 로고
    • Computational approaches to fragment and substructure discovery and evaluation
    • 1st ed.; Zartler, E.R.; Shapiro, M.J., Eds.; John Wiley & Sons
    • van der Horst, E.; Ijzerman, A.P. Computational Approaches to Fragment and Substructure Discovery and Evaluation. In: Fragment-Based Drug Discovery: a Practical Approach, 1st ed.; Zartler, E.R.; Shapiro, M.J., Eds.; John Wiley & Sons, 2008; pp. 199-222.
    • (2008) Fragment-Based Drug Discovery: A Practical Approach , pp. 199-222
    • Van Der Horst, E.1    Ijzerman, A.P.2
  • 129
    • 0012281570 scopus 로고    scopus 로고
    • HQSAR - A highly predictive QSAR technique based on molecular holograms
    • San Francisco, the USA, April 13-17
    • Hurst, T.; Heritage, T. HQSAR - a highly predictive QSAR technique based on molecular holograms. In: Book of Abstracts, 213th ACS National Meeting, San Francisco, the USA, April 13-17, 1997.
    • (1997) Book of Abstracts, 213th ACS National Meeting
    • Hurst, T.1    Heritage, T.2
  • 131
    • 1842639121 scopus 로고    scopus 로고
    • A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds
    • Waller, C.L. A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds. J. Chem. Inf. Comput. Sci., 1999, 44, 758-765.
    • (1999) J. Chem. Inf. Comput. Sci. , vol.44 , pp. 758-765
    • Waller, C.L.1
  • 132
    • 17844369895 scopus 로고    scopus 로고
    • Generalized fragment-substructure based property prediction method
    • DOI 10.1021/ci049744c
    • Clark, M. Generalized fragment-substructure based property prediction method. J. Chem. Inf. Model., 2005, 45, 30-38. (Pubitemid 40736953)
    • (2005) Journal of Chemical Information and Modeling , vol.45 , Issue.1 , pp. 30-38
    • Clark, M.1
  • 134
    • 0035438391 scopus 로고    scopus 로고
    • Is there a difference between leads and drugs? A historical perspective
    • Oprea, T.I.; Davis, A.M.; Teague, S.J.; Leeson, P.D. Is there a difference between leads and drugs? A historical perspective. J. Chem. Inf. Comput. Sci., 2001, 41, 1308-1315.
    • (2001) J. Chem. Inf. Comput. Sci. , vol.41 , pp. 1308-1315
    • Oprea, T.I.1    Davis, A.M.2    Teague, S.J.3    Leeson, P.D.4
  • 135
    • 4444262413 scopus 로고    scopus 로고
    • A minimalist approach to fragment-based ligand design using common rings and linkers: Application to kinase inhibitors
    • DOI 10.1002/prot.20173
    • Aronov, A.M.; Bemis, G.W. A minimalist approach to fragment-based ligand design using common rings and linkers: application to kinase inhibitors. Proteins, 2004, 57, 36-50. (Pubitemid 39195883)
    • (2004) Proteins: Structure, Function and Genetics , vol.57 , Issue.1 , pp. 36-50
    • Aronov, A.M.1    Bemis, G.W.2
  • 136
    • 41649105837 scopus 로고    scopus 로고
    • Kinase-likeness and kinase-privileged fragments: Toward virtual polypharmacology
    • DOI 10.1021/jm701021b
    • Aronov, A.M.; McClain, B.; Moody, C.S.; Murcko, M.A. Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology. J. Med. Chem., 2008, 51, 1214-1222. (Pubitemid 351480383)
    • (2008) Journal of Medicinal Chemistry , vol.51 , Issue.5 , pp. 1214-1222
    • Aronov, A.M.1    McClain, B.2    Moody, C.S.3    Murcko, M.A.4
  • 137
    • 1842690601 scopus 로고    scopus 로고
    • Molecular similarity searching using atom environments, information-based feature selection, and a naïve Bayesian classifier
    • Bender, A.; Mussa, H.Y.; Glen, R.C.; Reiling, S. Molecular similarity searching using atom environments, information-based feature selection, and a naïve Bayesian classifier. J. Chem. Inf. Comput. Sci., 2004, 44, 170-178.
    • (2004) J. Chem. Inf. Comput. Sci. , vol.44 , pp. 170-178
    • Bender, A.1    Mussa, H.Y.2    Glen, R.C.3    Reiling, S.4
  • 139
    • 23844449940 scopus 로고    scopus 로고
    • Computer-based de novo design of drug-like molecules
    • DOI 10.1038/nrd1799
    • Schneider, G.; Fechner, U. Computer-based de novo design of drug-like molecules. Nat. Rev. Drug Discov., 2005, 4, 649-663. (Pubitemid 41149759)
    • (2005) Nature Reviews Drug Discovery , vol.4 , Issue.8 , pp. 649-663
    • Schneider, G.1    Fechner, U.2
  • 140
    • 33845379303 scopus 로고
    • Atom pairs as molecular features in structure-activity studies: Definition and applications
    • Carhart, R.E.; Smith, D.H.; Venkataraghavan, R. Atom pairs as molecular features in structure-activity studies: definition and applications. J. Chem. Inf. Comput. Sci., 1985, 25, 64-73.
    • (1985) J. Chem. Inf. Comput. Sci. , vol.25 , pp. 64-73
    • Carhart, R.E.1    Smith, D.H.2    Venkataraghavan, R.3
  • 141
    • 3242672755 scopus 로고    scopus 로고
    • Approaches to target class combinatorial library design
    • Schnur, D.; Beno, B.R.; Good, A.; Tebben, A. Approaches to target class combinatorial library design. Methods Mol. Biol., 2004, 275, 355-378.
    • (2004) Methods Mol. Biol. , vol.275 , pp. 355-378
    • Schnur, D.1    Beno, B.R.2    Good, A.3    Tebben, A.4
  • 142
    • 33644839988 scopus 로고    scopus 로고
    • Diversity-oriented syn
    • thesis: exploring the intersections between chemistry and biology
    • Tan, D.S. Diversity-oriented synthesis: exploring the intersections between chemistry and biology. Nat. Chem. Biol., 2005, 1, 74-84.
    • (2005) Nat. Chem. Biol. , vol.1 , pp. 74-84
    • Tan, D.S.1
  • 144
    • 0002820943 scopus 로고
    • SPROUT, HIPPO and CAESA: Tools for de novo structure generation and estimation of synthetic accessibility
    • Gillet, V.J.; Myatt, G.; Zsoldos, Z.; Johnson, A.P. SPROUT, HIPPO and CAESA: tools for de novo structure generation and estimation of synthetic accessibility. Perspect. Drug Discov., 1995, 3, 34-50.
    • (1995) Perspect. Drug Discov. , vol.3 , pp. 34-50
    • Gillet, V.J.1    Myatt, G.2    Zsoldos, Z.3    Johnson, A.P.4
  • 145
    • 5444258821 scopus 로고    scopus 로고
    • Information content in organic molecules: Quantification and statistical structure via Brownian processing
    • Graham, D.J.; Malarkey, C.; Schulmerich, M.V. Information content in organic molecules: quantification and statistical structure via Brownian processing. J. Chem. Inf. Comput. Sci., 2004, 44, 1601-1611.
    • (2004) J. Chem. Inf. Comput. Sci. , vol.44 , pp. 1601-1611
    • Graham, D.J.1    Malarkey, C.2    Schulmerich, M.V.3
  • 146
    • 33750381015 scopus 로고    scopus 로고
    • Assessment of molecular similarity from the analysis of randomly generated structural fragment populations
    • DOI 10.1021/ci0601261
    • Batista, J.; Godden, J.W.; Bajorath, J. Assessment of molecular similarity from the analysis of randomly generated structural fragment populations. J. Chem. Inf. Model., 2006, 46, 1937-1944. (Pubitemid 44625965)
    • (2006) Journal of Chemical Information and Modeling , vol.46 , Issue.5 , pp. 1937-1944
    • Batista, J.1    Godden, J.W.2    Bajorath, J.3
  • 147
    • 34547678010 scopus 로고    scopus 로고
    • Mining of randomly generated molecular fragment populations uncovers activity-specific fragment hierarchies
    • DOI 10.1021/ci700108q
    • Batista, J.; Bajorath, J. Mining of randomly generated molecular fragment populations uncovers activity-specific fragment hierarchies. J. Chem. Inf. Model., 2007, 47, 1405-1413. (Pubitemid 47210044)
    • (2007) Journal of Chemical Information and Modeling , vol.47 , Issue.4 , pp. 1405-1413
    • Batista, J.1    Bajorath, J.2
  • 148
    • 37249031865 scopus 로고    scopus 로고
    • Mapping of activity-specific fragment pathways isolated from random fragment populations reveals the formation of coherent molecular cores
    • DOI 10.1021/ci700251b
    • Lounkine, E.; Batista, J.; Bajorath, J. Mapping of activity-specific fragment pathways isolated from random fragment populations reveals the formation of coherent molecular cores. J. Chem. Inf. Model., 2007, 47, 2133-2139. (Pubitemid 350275079)
    • (2007) Journal of Chemical Information and Modeling , vol.47 , Issue.6 , pp. 2133-2139
    • Lounkine, E.1    Batista, J.2    Bajorath, J.3
  • 149
    • 33846881583 scopus 로고    scopus 로고
    • Chemical database mining through entropy-based molecular similarity assessment of randomly generated structural fragment populations
    • DOI 10.1021/ci600377m
    • Batista, J.; Bajorath, J. Chemical database mining through entropy-based molecular similarity assessment of randomly generated structural fragment populations. J. Chem. Inf. Model., 2007, 47, 59-68. (Pubitemid 46225560)
    • (2007) Journal of Chemical Information and Modeling , vol.47 , Issue.1 , pp. 59-68
    • Batista, J.1    Bajorath, J.2
  • 150
    • 54849163800 scopus 로고    scopus 로고
    • Random molecular fragment methods in computational medicinal chemistry
    • Lounkine, E.; Batista, J.; Bajorath, J. Random molecular fragment methods in computational medicinal chemistry. Curr. Med. Chem., 2008, 15, 2108-2121.
    • (2008) Curr. Med. Chem. , vol.15 , pp. 2108-2121
    • Lounkine, E.1    Batista, J.2    Bajorath, J.3
  • 152
    • 10344230435 scopus 로고    scopus 로고
    • Molecular similarity: A key technique in molecular informatics
    • Bender, A.; Glen, R.C. Molecular similarity: a key technique in molecular informatics. Org. Biomol. Chem., 2004, 2, 3204-3218.
    • (2004) Org. Biomol. Chem. , vol.2 , pp. 3204-3218
    • Bender, A.1    Glen, R.C.2
  • 153
    • 33846465344 scopus 로고    scopus 로고
    • Chemical diversity and biological activity
    • DOI 10.1016/j.ddtec.2006.12.007, PII S1740674906000801
    • Schuffenhauer, A.; Brown, N. Chemical diversity and biological activity. Drug Discov. Today Technol., 2006, 3, 387-395. (Pubitemid 46158394)
    • (2006) Drug Discovery Today: Technologies , vol.3 , Issue.4 , pp. 387-395
    • Schuffenhauer, A.1    Brown, N.2
  • 154
    • 33646242741 scopus 로고    scopus 로고
    • Assessing the scaffold diversity of screening libraries
    • Krier, M.; Bret, G.; Rognan, D. Assessing the scaffold diversity of screening libraries. J. Chem. Inf. Model., 2006, 46, 512-524.
    • (2006) J. Chem. Inf. Model. , vol.46 , pp. 512-524
    • Krier, M.1    Bret, G.2    Rognan, D.3
  • 155
    • 77249139237 scopus 로고    scopus 로고
    • Systematic analysis of public domain compound potency data identifies selective molecular scaffolds across druggable target families
    • Hu, Y.; Wassermann, A.M.; Lounkine, E.; Bajorath, J. Systematic analysis of public domain compound potency data identifies selective molecular scaffolds across druggable target families. J. Med. Chem., 2010, 53, 752-758.
    • (2010) J. Med. Chem. , vol.53 , pp. 752-758
    • Hu, Y.1    Wassermann, A.M.2    Lounkine, E.3    Bajorath, J.4
  • 158
    • 0037498077 scopus 로고    scopus 로고
    • Use of recursion forests in the sequential screening process: Consensus selection by multiple recursion trees
    • van Rhee, A.M. Use of recursion forests in the sequential screening process: consensus selection by multiple recursion trees. J. Chem. Inf. Comput. Sci., 2003, 43, 941-948.
    • (2003) J. Chem. Inf. Comput. Sci. , vol.43 , pp. 941-948
    • Van Rhee, A.M.1
  • 159
    • 0034780805 scopus 로고    scopus 로고
    • Fragment-based flexible ligand docking by evolutionary optimization
    • DOI 10.1515/BC.2001.168
    • Budin, N.; Majeux, N.; Caflisch, A. Fragment-based flexible ligand docking by evolutionary optimization. Biol. Chem., 2001, 382, 1365-1372. (Pubitemid 32976495)
    • (2001) Biological Chemistry , vol.382 , Issue.9 , pp. 1365-1372
    • Budin, N.1    Majeux, N.2    Caflisch, A.3
  • 160
    • 0000424557 scopus 로고    scopus 로고
    • Intramolecular hydrogen bonds: Common motifs, probabilities of formation and implications for supramolecular organization
    • Bilton, C.; Allen, F.H.; Shields, G.P.; Howard, J.A. Intramolecular hydrogen bonds: common motifs, probabilities of formation and implications for supramolecular organization. Acta Crystallogr. B, 2000, 56, 849-856.
    • (2000) Acta Crystallogr. B , vol.56 , pp. 849-856
    • Bilton, C.1    Allen, F.H.2    Shields, G.P.3    Howard, J.A.4
  • 161
    • 79960695275 scopus 로고    scopus 로고
    • Databases and their use for studying intermolecular interactions
    • Martin, Y.C; Willett, P., Eds.; ACS: Washington, DC
    • Pitchford, N.A.; Taylor, R. Crystallographic Databases and Their Use for Studying Intermolecular Interactions. In: Designing Bioactive Molecules; Martin, Y.C; Willett, P., Eds.; ACS: Washington, DC, 1998; pp. 19-46.
    • (1998) Designing Bioactive Molecules , pp. 19-46
    • Pitchford, N.A.1    Taylor, R.2
  • 162
    • 12144254795 scopus 로고    scopus 로고
    • β-Diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors
    • DOI 10.1021/jm0496077
    • Dayam, R.; Sanchez, T.; Clement, O.; Shoemaker, R.; Sei, S.; Neamati, N. β-Diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors. J. Med. Chem., 2005, 48, 111-120. (Pubitemid 40105252)
    • (2005) Journal of Medicinal Chemistry , vol.48 , Issue.1 , pp. 111-120
    • Dayam, R.1    Sanchez, T.2    Clement, O.3    Shoemaker, R.4    Sei, S.5    Neamati, N.6
  • 164
    • 77956308900 scopus 로고    scopus 로고
    • Binding-site assessment by virtual fragment screening
    • Huang, N.; Jacobson, M.P. Binding-site assessment by virtual fragment screening. PLoS One, 2010, 5, e10109.
    • (2010) PLoS One , vol.5
    • Huang, N.1    Jacobson, M.P.2
  • 165
    • 34547691007 scopus 로고    scopus 로고
    • GPCR structure-based virtual screening approach for CB2 antagonist search
    • DOI 10.1021/ci7000814
    • Chen, J.Z.; Wang, J.; Xie, X.Q. GPCR structure-based virtual screening approach for CB2 antagonist search. J. Chem. Inf. Model., 2007, 47, 1626-1637. (Pubitemid 47210066)
    • (2007) Journal of Chemical Information and Modeling , vol.47 , Issue.4 , pp. 1626-1637
    • Chen, J.-Z.1    Wang, J.2    Xie, X.-Q.3
  • 166
    • 84860510662 scopus 로고    scopus 로고
    • Role of natural products in drug discovery
    • Rankovic, Z.; Morphy, R., Eds.; John Wiley & Sons: New York
    • Lachance, H.; Wetzel, S.; Waldmann H. Role of natural products in drug discovery. In: Lead Generation Approaches in Drug Discovery; Rankovic, Z.; Morphy, R., Eds.; John Wiley & Sons: New York, 2010; pp. 187-229.
    • (2010) Lead Generation Approaches in Drug Discovery , pp. 187-229
    • Lachance, H.1    Wetzel, S.2    Waldmann, H.3
  • 167
    • 39149137869 scopus 로고    scopus 로고
    • Plant-derived compounds in clinical trials
    • Saklani, A.; Kutty, S.K. Plant-derived compounds in clinical trials. Drug Discov. Today, 2008, 13, 161-171.
    • (2008) Drug Discov. Today , vol.13 , pp. 161-171
    • Saklani, A.1    Kutty, S.K.2
  • 168
    • 42949149681 scopus 로고    scopus 로고
    • Modern natural products chemistry and drug discovery
    • DOI 10.1021/jm701291u
    • Ojima, I. Modern natural products chemistry and drug discovery. J. Med. Chem., 2008, 51, 2587-2588. (Pubitemid 351620777)
    • (2008) Journal of Medicinal Chemistry , vol.51 , Issue.9 , pp. 2587-2588
    • Ojima, I.1
  • 169
    • 0035347869 scopus 로고    scopus 로고
    • Scaffold architecture and pharmacophoric properties of natural products and trade drugs: Application in the design of natural product-based combinatorial libraries
    • DOI 10.1021/cc000097l
    • Lee, M.L.; Schneider, G. Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries. J. Comb. Chem., 2001, 3, 284-289. (Pubitemid 33616450)
    • (2001) Journal of Combinatorial Chemistry , vol.3 , Issue.3 , pp. 284-289
    • Lee, M.-L.1    Schneider, G.2
  • 170
    • 0037208308 scopus 로고    scopus 로고
    • Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry
    • Feher, M.; Schmidt, J.M. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J. Chem. Inf. Comput. Sci., 2003, 43, 218-227.
    • (2003) J. Chem. Inf. Comput. Sci. , vol.43 , pp. 218-227
    • Feher, M.1    Schmidt, J.M.2
  • 171
    • 67349190954 scopus 로고    scopus 로고
    • The chemist as astronaut: Searching for biologically useful space in the chemical universe
    • Triggle, D.J. The chemist as astronaut: searching for biologically useful space in the chemical universe. Biochem. Pharmacol., 2009, 78, 217-223.
    • (2009) Biochem. Pharmacol. , vol.78 , pp. 217-223
    • Triggle, D.J.1
  • 172
    • 42949115495 scopus 로고    scopus 로고
    • Cheminformatics analysis of natural products: Lessons from nature inspiring the design of new drugs
    • Ertl, P.; Schuffenhauer, A. Cheminformatics analysis of natural products: lessons from nature inspiring the design of new drugs. Prog. Drug Res., 2008, 66, 217,219-235.
    • (2008) Prog. Drug Res. , vol.66 , Issue.217 , pp. 219-235
    • Ertl, P.1    Schuffenhauer, A.2
  • 173
    • 52649134945 scopus 로고    scopus 로고
    • Scaffold diversity of natural products: Inspiration for combinatorial library design
    • Grabowski, K.; Baringhaus, K.H.; Schneider, G. Scaffold diversity of natural products: inspiration for combinatorial library design. Nat. Prod. Rep., 2008, 25, 892-904.
    • (2008) Nat. Prod. Rep. , vol.25 , pp. 892-904
    • Grabowski, K.1    Baringhaus, K.H.2    Schneider, G.3
  • 176
    • 0002283033 scopus 로고    scopus 로고
    • From data mining to knowledge discovery in databases
    • Fayyad, U.; Piatetsky-Shapiro, G.; Smyth, P. From data mining to knowledge discovery in databases. AI Magazine, 1996, 17, 37-54.
    • (1996) AI Magazine , vol.17 , pp. 37-54
    • Fayyad, U.1    Piatetsky-Shapiro, G.2    Smyth, P.3
  • 177
    • 79960674168 scopus 로고    scopus 로고
    • Mapping fragmental druglikeness in the MoStBioDat environment: Intramolecular hydrogen bonding motifs in β -ketoenols
    • Bak, A.; Magdziarz, T.; Kurczyk, A.; Polanski, J. Mapping fragmental druglikeness in the MoStBioDat environment: intramolecular hydrogen bonding motifs in β -ketoenols. Comb. Chem. High Throughput Screen., 2011, 14, 560-569.
    • (2011) Comb. Chem. High Throughput Screen. , vol.14 , pp. 560-569
    • Bak, A.1    Magdziarz, T.2    Kurczyk, A.3    Polanski, J.4
  • 178
    • 61949359014 scopus 로고    scopus 로고
    • Common pharmacophore identification using frequent clique detection algorithm
    • Podolyan, Y.; Karypis, G. Common pharmacophore identification using frequent clique detection algorithm. J. Chem. Inf. Model., 2009, 49, 13-21.
    • (2009) J. Chem. Inf. Model. , vol.49 , pp. 13-21
    • Podolyan, Y.1    Karypis, G.2
  • 181
    • 0000010226 scopus 로고    scopus 로고
    • Novel canonical coding method for representation of three-dimensional structures
    • Satoh, H.; Koshin, H.; Funatsu, K.; Nakata, T. Novel canonical coding method for representation of three-dimensional structures. J. Chem. Inf. Comput. Sci., 2000, 40, 622-630.
    • (2000) J. Chem. Inf. Comput. Sci. , vol.40 , pp. 622-630
    • Satoh, H.1    Koshin, H.2    Funatsu, K.3    Nakata, T.4
  • 182
  • 183
    • 62549107911 scopus 로고    scopus 로고
    • Quinolone antibiotics: The development of moxifloxacin
    • Fischer, J.; Ganellin, C.R., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim
    • Petersen, U. Quinolone Antibiotics: The Development of Moxifloxacin. In: Analogue-Based Drug Discovery; Fischer, J.; Ganellin, C.R., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, 2006; pp. 315-370.
    • (2006) Analogue-Based Drug Discovery , pp. 315-370
    • Petersen, U.1
  • 188
    • 3042767495 scopus 로고    scopus 로고
    • Ferroquine: A new weapon in the fight against malaria
    • DOI 10.2174/1568012043354008
    • Biot, C. Ferroquine: a new weapon in the fight against malaria. Curr. Med. Chem.: Anti-Infect. Agents, 2004, 3, 135-147. (Pubitemid 38864706)
    • (2004) Current Medicinal Chemistry: Anti-Infective Agents , vol.3 , Issue.2 , pp. 135-147
    • Biot, C.1
  • 190
    • 33644841699 scopus 로고    scopus 로고
    • Screening for antimicrobial activity of ten medicinal plants used in Colombian folkloric medicine: A possible alternative in the treatment of non-nosocomial infections
    • Rojas, J.J.; Ochoa, V.J.; Ocampo, S.A.; Munoz, J.F.; Screening for antimicrobial activity of ten medicinal plants used in Colombian folkloric medicine: a possible alternative in the treatment of non-nosocomial infections. BMC Complement. Altern. Med., 2006, 6, 2.
    • (2006) BMC Complement. Altern. Med. , vol.6 , pp. 2
    • Rojas, J.J.1    Ochoa, V.J.2    Ocampo, S.A.3    Munoz, J.F.4
  • 192
    • 62949190997 scopus 로고    scopus 로고
    • Muscle cramps - Differential diagnosis and therapy
    • Reichel, G. Muscle cramps - differential diagnosis and therapy. Med. Monatsschr. Pharm., 2009, 32, 80-86.
    • (2009) Med. Monatsschr. Pharm. , vol.32 , pp. 80-86
    • Reichel, G.1
  • 195
    • 34250778472 scopus 로고    scopus 로고
    • Die Jagd auf Chinin: Etappenerfolge und Gesamtsiege
    • Kaufman, T.S.; Ruveda, E.A. Die Jagd auf Chinin: Etappenerfolge und Gesamtsiege. Angew. Chem., 2005, 117, 876-907.
    • (2005) Angew. Chem. , vol.117 , pp. 876-907
    • Kaufman, T.S.1    Ruveda, E.A.2
  • 196
    • 79851474042 scopus 로고    scopus 로고
    • Is chloroquine making a comeback?
    • Hand, C.C.; Meshnick, S.R. Is chloroquine making a comeback? J. Infect. Dis., 2011, 203, 11-12.
    • (2011) J. Infect. Dis. , vol.203 , pp. 11-12
    • Hand, C.C.1    Meshnick, S.R.2
  • 198
    • 0021633432 scopus 로고
    • Norfloxacin - a review of pharmacology and tissue penetration
    • Wise, R. Norfloxacin - a review of pharmacology and tissue penetration. J. Antimicrob. Chemother., 1984, 13 Suppl B, 59-64. (Pubitemid 15075781)
    • (1984) Journal of Antimicrobial Chemotherapy , vol.13 , Issue.SUPPL. B , pp. 59-64
    • Wise, R.1
  • 199
    • 0038778607 scopus 로고    scopus 로고
    • The quinolones: Decades of development and use
    • Emmerson, A.M.; Jones, A.M. The quinolones: decades of development and use. J. Antimicrob. Chemother., 2003, 51 Suppl 1, 13-20. (Pubitemid 36622100)
    • (2003) Journal of Antimicrobial Chemotherapy , vol.51 , Issue.SUPPL. 1 , pp. 13-20
    • Emmerson, A.M.1    Jones, A.M.2
  • 200
    • 0024997687 scopus 로고
    • Demonstration of quinolone phototoxicity in vitro
    • Przybilla, B.; Georgii, A.; Bergner, T.; Ring, J. Demonstration of quinolone phototoxicity in vitro. Dermatologica, 1990, 181, 98-103. (Pubitemid 20263275)
    • (1990) Dermatologica , vol.181 , Issue.2 , pp. 98-103
    • Przybilla, B.1    Georgii, A.2    Bergner, T.3    Ring, J.4
  • 201
    • 0032971470 scopus 로고    scopus 로고
    • Expanded activity and utility of the new fluoroquinolones: A review
    • DOI 10.1016/S0149-2918(00)88266-1
    • Blondeau, J.M. Expanded activity and utility of the new fluoroquinolones: a review. Clin. Ther., 1999, 21, 3-40. (Pubitemid 29106688)
    • (1999) Clinical Therapeutics , vol.21 , Issue.1 , pp. 3-40
    • Blondeau, J.M.1
  • 202
    • 70350726100 scopus 로고    scopus 로고
    • The newer fluoroquinolones
    • Bolon, M.K. The newer fluoroquinolones. Infect. Dis. Clin. North Am., 2009, 23, 1027-1051.
    • (2009) Infect. Dis. Clin. North Am. , vol.23 , pp. 1027-1051
    • Bolon, M.K.1
  • 203
    • 33745016515 scopus 로고    scopus 로고
    • Pharmacology of the fluoroquinolones: A perspective for the use in domestic animals
    • DOI 10.1016/j.tvjl.2005.07.010, PII S1090023305001814
    • Martinez, M.; McDermott, P.; Walker, R. Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals. Vet. J., 2006, 172, 10-28. (Pubitemid 43869434)
    • (2006) Veterinary Journal , vol.172 , Issue.1 , pp. 10-28
    • Martinez, M.1    McDermott, P.2    Walker, R.3
  • 204
    • 21844444791 scopus 로고    scopus 로고
    • Antimicrobial safety: Focus on fluoroquinolones
    • Owens, R.C.; Ambrose, P.G. Antimicrobial safety: focus on fluoroquinolones. Clin. Infect. Dis., 2005, 41 Suppl 2, S144-157. (Pubitemid 40962485)
    • (2005) Clinical Infectious Diseases , vol.41 , Issue.SUPPL.
    • Owens Jr., R.C.1    Ambrose, P.G.2
  • 205
    • 80053477373 scopus 로고    scopus 로고
    • The use of systemic and topical fluoroquinolones
    • Bradley, J.S.; Jackson, M.A. The use of systemic and topical fluoroquinolones. Pediatrics, 2011, 128, e1034-1045.
    • (2011) Pediatrics , vol.128
    • Bradley, J.S.1    Jackson, M.A.2
  • 206
    • 0344825065 scopus 로고    scopus 로고
    • Development of fluoroquinolones as first-line drugs for tuberculosis - At long last!
    • O'Brien, R.J. Development of fluoroquinolones as first-line drugs for tuberculosis - at long last! Am. J. Respir. Crit. Care Med., 2003, 168, 1266-1268.
    • (2003) Am. J. Respir. Crit. Care Med. , vol.168 , pp. 1266-1268
    • O'brien, R.J.1
  • 207
    • 77954688186 scopus 로고    scopus 로고
    • 6-desfluoroquinolones as HIV-1 Tat-mediated transcription inhibitors
    • Tabarrini, O.; Massari, S.; Cecchetti, V. 6-desfluoroquinolones as HIV-1 Tat-mediated transcription inhibitors. Future Med. Chem., 2010, 2, 1161-1180.
    • (2010) Future Med. Chem. , vol.2 , pp. 1161-1180
    • Tabarrini, O.1    Massari, S.2    Cecchetti, V.3
  • 208
    • 67651047155 scopus 로고    scopus 로고
    • The 4-quinolone-3-carboxylic acid motif as a multivalent scaffold in medicinal chemistry
    • Mugnaini, C.; Pasquini, S.; Corelli, F. The 4-quinolone-3-carboxylic acid motif as a multivalent scaffold in medicinal chemistry. Curr. Med. Chem., 2009, 16, 1746-1767.
    • (2009) Curr. Med. Chem. , vol.16 , pp. 1746-1767
    • Mugnaini, C.1    Pasquini, S.2    Corelli, F.3
  • 209
    • 27744586780 scopus 로고    scopus 로고
    • Endovascular treatment of cerebral vasospasm: Transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine
    • DOI 10.1016/j.nec.2005.04.004, PII S1042368005000264
    • Hoh, B.L.; Ogilvy, C.S. Endovascular treatment of cerebral vasospasm: transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine. Neurosurg. Clin. N. Am., 2005, 16, 501-516. (Pubitemid 41766378)
    • (2005) Neurosurgery Clinics of North America , vol.16 , Issue.3 , pp. 501-516
    • Hoh, B.L.1    Ogilvy, C.S.2
  • 210
    • 24644465551 scopus 로고    scopus 로고
    • Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage
    • DOI 10.1385/NCC:2:2:124
    • Liu, J.K.; Couldwell, W.T. Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage. Neurocrit. Care, 2005, 2, 124-132. (Pubitemid 41270855)
    • (2005) Neurocritical Care , vol.2 , Issue.2 , pp. 124-132
    • Liu, J.K.1    Couldwell, W.T.2
  • 212
    • 33750476339 scopus 로고    scopus 로고
    • Neurointerventional treatment of vasospasm
    • DOI 10.1179/016164106X152043
    • Brisman, J.L.; Eskridge, J.M.; Newell, D.W. Neurointerventional treatment of vasospasm. Neurol. Res., 2006, 28, 769-776. (Pubitemid 44656103)
    • (2006) Neurological Research , vol.28 , Issue.7 , pp. 769-776
    • Brisman, J.L.1    Eskridge, J.M.2    Newell, D.W.3
  • 213
    • 27744542228 scopus 로고    scopus 로고
    • Available and future treatments for erectile dysfunction
    • Dinsmore, W.W. Available and future treatments for erectile dysfunction. Clin. Cornerstone, 2005, 7, 37-45.
    • (2005) Clin. Cornerstone , vol.7 , pp. 37-45
    • Dinsmore, W.W.1
  • 214
    • 23744435642 scopus 로고    scopus 로고
    • A comparative review of the options for treatment of erectile dysfunction: Which treatment for which patient?
    • DOI 10.2165/00003495-200565120-00003
    • Hatzimouratidis, K.; Hatzichristou, D.G. A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient? Drugs, 2005, 65, 1621-1650. (Pubitemid 41138985)
    • (2005) Drugs , vol.65 , Issue.12 , pp. 1621-1650
    • Hatzimouratidis, K.1    Hatzichristou, D.G.2
  • 215
    • 70349404397 scopus 로고    scopus 로고
    • Quinaprilat: A review of its pharmacokinetics, pharmacodynamics, toxicological data and clinical application
    • Kieback, A.G.; Felix, S.B.; Reffelmann, T. Quinaprilat: a review of its pharmacokinetics, pharmacodynamics, toxicological data and clinical application. Expert Opin. Drug. Metab. Toxicol., 2009, 5, 1337-1347.
    • (2009) Expert Opin. Drug. Metab. Toxicol. , vol.5 , pp. 1337-1347
    • Kieback, A.G.1    Felix, S.B.2    Reffelmann, T.3
  • 217
    • 79955919708 scopus 로고    scopus 로고
    • Clinical pharmacokinetics of tyrosine kinase inhibitors: Focus on 4-anilinoquinazolines
    • Scheffler, M.; Gion, P.D; Doroshyenko, O.; Wolf, J.; Fuhr, U. Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on 4-anilinoquinazolines. Clin. Pharmacokinet., 2011, 50, 371-403.
    • (2011) Clin. Pharmacokinet. , vol.50 , pp. 371-403
    • Scheffler, M.1    Gion, P.D.2    Doroshyenko, O.3    Wolf, J.4    Fuhr, U.5
  • 218
    • 77957335553 scopus 로고    scopus 로고
    • Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer
    • Shao, Y.Y.; Lin, C.C.; Yang, C.H. Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer. Discov. Med., 2010, 9, 538-545.
    • (2010) Discov. Med. , vol.9 , pp. 538-545
    • Shao, Y.Y.1    Lin, C.C.2    Yang, C.H.3
  • 220
    • 60449108971 scopus 로고    scopus 로고
    • Structure-activity studies of echinomycin antibiotics against drug-resistant and biofilm-forming Staphylococcus aureus and Enterococcus faecalis
    • Socha, A.M.; Laplante, K.L.; Russell, D.J.; Rowley, D.C. Structure-activity studies of echinomycin antibiotics against drug-resistant and biofilm-forming Staphylococcus aureus and Enterococcus faecalis. Bioorg. Med. Chem., 2009, 19, 1504-1507.
    • (2009) Bioorg. Med. Chem. , vol.19 , pp. 1504-1507
    • Socha, A.M.1    Laplante, K.L.2    Russell, D.J.3    Rowley, D.C.4
  • 221
    • 33645129089 scopus 로고    scopus 로고
    • Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms
    • Sandoe, J.A.T.; Wysome, J.; West, A.P.; Heritage, J.; Wilcox, M.H. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms. J. Antimicrob. Chemother., 2006, 57, 767-770.
    • (2006) J. Antimicrob. Chemother. , vol.57 , pp. 767-770
    • Sandoe, J.A.T.1    Wysome, J.2    West, A.P.3    Heritage, J.4    Wilcox, M.H.5
  • 222
    • 8844258137 scopus 로고    scopus 로고
    • In vitro antibacterial activity of echinomycin and a novel analogue, YK2000, against vancomycin-resistant enterococci
    • DOI 10.1016/j.ijantimicag.2004.03.018, PII S0924857904001803
    • Kim, J.B.; Lee, G.S.; Kim, Y.B.; Kim, S.K.; Kim, Y.H.; In vitro antibacterial activity of echinomycin and a novel analogue, YK2000, against vancomycinresistant enterococci. Int. J. Antimicrob. Agents, 2004, 24, 613-615. (Pubitemid 39536119)
    • (2004) International Journal of Antimicrobial Agents , vol.24 , Issue.6 , pp. 613-615
    • Kim, J.-B.1    Lee, G.-S.2    Kim, Y.-B.3    Kim, S.-K.4    Kim, Y.H.5
  • 223
    • 84856120428 scopus 로고    scopus 로고
    • A Comparison of Dequalinium Chloride Vaginal Tablets (Fluomizin®) and Clindamycin Vaginal Cream in the Treatment of Bacterial Vaginosis: A Single-Blind, Randomized Clinical Trial of Efficacy and Safety
    • Epub ahead of print
    • Weissenbacher, E.R.; Donders, G.; Unzeitig, V.; Martinez de Tejada, B.; Gerber, S.; Halaska, M.; Spacek, J. A Comparison of Dequalinium Chloride Vaginal Tablets (Fluomizin®) and Clindamycin Vaginal Cream in the Treatment of Bacterial Vaginosis: A Single-Blind, Randomized Clinical Trial of Efficacy and Safety. Gynecol. Obstet. Invest., 2012, Epub ahead of print.
    • (2012) Gynecol. Obstet. Invest.
    • Weissenbacher, E.R.1    Donders, G.2    Unzeitig, V.3    Martinez De Tejada, B.4    Gerber, S.5    Halaska, M.6    Spacek, J.7
  • 224
    • 79951709246 scopus 로고    scopus 로고
    • Antimicrobial topical agents used in the vagina
    • Frey Tirri, B. Antimicrobial topical agents used in the vagina. Curr. Probl. Dermatol., 2011, 40, 36-47.
    • (2011) Curr. Probl. Dermatol. , vol.40 , pp. 36-47
    • Frey Tirri, B.1
  • 226
    • 4444358344 scopus 로고    scopus 로고
    • Camptothecins and topoisomerase I: A foot in the door. Targeting the genome beyond topoisomerase I with camptothecins and novel anticancer drugs: Importance of DNA replication, repair and cell cycle checkpoints
    • DOI 10.2174/1568011043352777
    • Pommier, Y. Camptothecins and topoisomerase I: a foot in the door. Targeting the genome beyond topoisomerase I with camptothecins and novel anticancer drugs: importance of DNA replication, repair and cell cycle checkpoints. Curr. Med. Chem. Anticancer Agents, 2004, 4, 429-434. (Pubitemid 39199346)
    • (2004) Current Medicinal Chemistry - Anti-Cancer Agents , vol.4 , Issue.5 , pp. 429-434
    • Pommier, Y.1
  • 227
    • 33749034730 scopus 로고    scopus 로고
    • Topoisomerase I inhibitors: Camptothecins and beyond
    • DOI 10.1038/nrc1977, PII NRC1977
    • Pommier, Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer, 2006, 6, 789-802. (Pubitemid 44450467)
    • (2006) Nature Reviews Cancer , vol.6 , Issue.10 , pp. 789-802
    • Pommier, Y.1
  • 228
    • 79953839433 scopus 로고    scopus 로고
    • CRLX101 (formerly IT-101) - A novel nanopharmaceutical of camptothecin in clinical development
    • Young, C.; Schluep, T.; Hwang, J.; Eliasof, S. CRLX101 (formerly IT-101) - a novel nanopharmaceutical of camptothecin in clinical development. Curr. Bioact. Compd., 2011, 7, 8-14.
    • (2011) Curr. Bioact. Compd. , vol.7 , pp. 8-14
    • Young, C.1    Schluep, T.2    Hwang, J.3    Eliasof, S.4
  • 230
    • 84860542238 scopus 로고    scopus 로고
    • Preclinical study of the cyclodextrin-polymer conjugate of camptothecin CRLX101 for the treatment of gastric cancer
    • Epub ahead of print
    • Gaur, S.; Chen, L.; Yen, T.; Wang, Y.; Zhou, B.; Davis, M.; Yen, Y. Preclinical study of the cyclodextrin-polymer conjugate of camptothecin CRLX101 for the treatment of gastric cancer. Nanomedicine, 2011, Epub ahead of print.
    • (2011) Nanomedicine
    • Gaur, S.1    Chen, L.2    Yen, T.3    Wang, Y.4    Zhou, B.5    Davis, M.6    Yen, Y.7
  • 231
    • 10444272941 scopus 로고    scopus 로고
    • Antitumor activity of beta-cyclodextrin polymer-camptothecin conjugates
    • Cheng, J.; Khin, K.T.; Davis, M.E. Antitumor activity of beta-cyclodextrin polymer-camptothecin conjugates. Mol. Pharm., 2004, 1, 183-193.
    • (2004) Mol. Pharm. , vol.1 , pp. 183-193
    • Cheng, J.1    Khin, K.T.2    Davis, M.E.3
  • 233
    • 0036399299 scopus 로고    scopus 로고
    • Camptothecins: A review of their chemotherapeutic potential
    • Ulukan, H.; Swaan, P.W. Camptothecins: a review of their chemotherapeutic potential. Drugs, 2002, 62, 2039-2057. (Pubitemid 35204037)
    • (2002) Drugs , vol.62 , Issue.14 , pp. 2039-2057
    • Ulukan, H.1    Swaan, P.W.2
  • 235
    • 80054767978 scopus 로고    scopus 로고
    • Metabolic activation of irinotecan during intra-arterial chemotherapy of metastatic colorectal cancer
    • Czejka, M.; Kiss, A.; Koessner, C.; Terkola, R.; Ettlinger, D.; Schueller, J. Metabolic activation of irinotecan during intra-arterial chemotherapy of metastatic colorectal cancer. Anticancer Res., 2011, 31, 3573-3578.
    • (2011) Anticancer Res. , vol.31 , pp. 3573-3578
    • Czejka, M.1    Kiss, A.2    Koessner, C.3    Terkola, R.4    Ettlinger, D.5    Schueller, J.6
  • 236
    • 80052269036 scopus 로고    scopus 로고
    • Pharmacokinetics of SN2310, an injectable emulsion that incorporates a new derivative of SN-38 in patients with advanced solid tumors
    • Epub ahead of print
    • Marier, J.F.; Pheng, L.; Trinh, M.M.; Burris, H.A.; Jones, S.; Anderson, K.; Warner, S.; Porubek, D. Pharmacokinetics of SN2310, an injectable emulsion that incorporates a new derivative of SN-38 in patients with advanced solid tumors. J. Pharm. Sci., 2011, Epub ahead of print.
    • (2011) J. Pharm. Sci.
    • Marier, J.F.1    Pheng, L.2    Trinh, M.M.3    Burris, H.A.4    Jones, S.5    Anderson, K.6    Warner, S.7    Porubek, D.8
  • 237
    • 70349645655 scopus 로고    scopus 로고
    • Marked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin's lymphoma
    • Sapra, P.; Kraft, P.; Mehlig, M.; Malaby, J.; Zhao, H.; Greenberger, L.M.; Horak, I.D. Marked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin's lymphoma. Haematologica, 2009, 94, 1456-1459.
    • (2009) Haematologica , vol.94 , pp. 1456-1459
    • Sapra, P.1    Kraft, P.2    Mehlig, M.3    Malaby, J.4    Zhao, H.5    Greenberger, L.M.6    Horak, I.D.7
  • 239
    • 41549105038 scopus 로고    scopus 로고
    • Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model
    • DOI 10.1158/1078-0432.CCR-07-4456
    • Sapra, P.; Zhao, H.; Mehlig, M.; Malaby, J.; Kraft, P.; Longley, C.; Greenberger, L.M.; Horak, I.D. Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model. Clin. Cancer Res., 2008, 14, 1888-1896. (Pubitemid 351469476)
    • (2008) Clinical Cancer Research , vol.14 , Issue.6 , pp. 1888-1896
    • Sapra, P.1    Zhao, H.2    Mehlig, M.3    Malaby, J.4    Kraft, P.5    Longley, C.6    Greenberger, L.M.7    Horak, I.D.8
  • 240
    • 77749264641 scopus 로고    scopus 로고
    • 28th annual JPMorgan healthcare conference - Exelixis and nektar therapeutics
    • Gale, S.; Croasdell, G. 28th Annual JPMorgan Healthcare Conference - Exelixis and Nektar Therapeutics. IDrugs., 2010, 13, 139-141.
    • (2010) IDrugs. , vol.13 , pp. 139-141
    • Gale, S.1    Croasdell, G.2
  • 242
    • 84857181385 scopus 로고    scopus 로고
    • Novel molecular targets for the therapy of castration-resistant prostate cancer
    • Epub ahead of print
    • Agarwal, N.; Sonpavde, G.; Sternberg, C.N. Novel molecular targets for the therapy of castration-resistant prostate cancer. Eur. Urol., 2011, Epub ahead of print.
    • (2011) Eur. Urol.
    • Agarwal, N.1    Sonpavde, G.2    Sternberg, C.N.3
  • 243
    • 77952223624 scopus 로고    scopus 로고
    • Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors
    • Olsson, A.; Bjork, A.; Vallon-Christersson, J.; Isaacs, J.T.; Leanderson, T. Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors. Mol. Cancer, 2010, 9, 107.
    • (2010) Mol. Cancer , vol.9 , pp. 107
    • Olsson, A.1    Bjork, A.2    Vallon-Christersson, J.3    Isaacs, J.T.4    Leanderson, T.5
  • 244
    • 70349952393 scopus 로고    scopus 로고
    • Clinical phase i studies of tasquinimod in patients with castration-resistant prostate cancer
    • Bratt, O.; Haggman, M.; Ahlgren, G.; Nordle, O.; Bjork, A.; Damber, J.E. Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer. Br. J. Cancer, 2009, 101, 1233-1240.
    • (2009) Br. J. Cancer , vol.101 , pp. 1233-1240
    • Bratt, O.1    Haggman, M.2    Ahlgren, G.3    Nordle, O.4    Bjork, A.5    Open-Label, E.D.J.6
  • 245
    • 79959640311 scopus 로고    scopus 로고
    • Extracts of Canadian first nations medicinal plants, used as natural products, inhibit neisseria gonorrhoeae isolates with different antibiotic resistance profiles
    • Cybulska, P.; Thakur, S.D.; Foster, B.C.; Scott, I.M.; Leduc, R.I.; Arnason, J.T.; Dillon, J.A.R. Extracts of Canadian first nations medicinal plants, used as natural products, inhibit neisseria gonorrhoeae isolates with different antibiotic resistance profiles. Sex. Transm. Dis., 2011, 38, 667-671.
    • (2011) Sex. Transm. Dis. , vol.38 , pp. 667-671
    • Cybulska, P.1    Thakur, S.D.2    Foster, B.C.3    Scott, I.M.4    Leduc, R.I.5    Arnason, J.T.6    Dillon, J.A.R.7
  • 246
    • 31044440371 scopus 로고    scopus 로고
    • Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus
    • Yu, H.H.; Kim, K.J.; Cha, J.D.; Kim, H.K.; Lee, Y.E.; Choi, N.Y.; You, Y.O. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. J. Med. Food, 2005, 8, 454-461.
    • (2005) J. Med. Food , vol.8 , pp. 454-461
    • Yu, H.H.1    Kim, K.J.2    Cha, J.D.3    Kim, H.K.4    Lee, Y.E.5    Choi, N.Y.6    You, Y.O.7
  • 247
    • 36148962372 scopus 로고    scopus 로고
    • Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells
    • DOI 10.1016/j.canlet.2007.09.007, PII S0304383507004375
    • Piyanuch, R.; Sukhthankar, M.; Wandee, G.; Baek, S.J. Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells. Cancer Lett., 2007, 258, 230-240. (Pubitemid 350110378)
    • (2007) Cancer Letters , vol.258 , Issue.2 , pp. 230-240
    • Piyanuch, R.1    Sukhthankar, M.2    Wandee, G.3    Baek, S.J.4
  • 249
    • 77954383397 scopus 로고    scopus 로고
    • Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia
    • Izzo, R.; de Simone, G.; Giudice, R.; Chinali, M.; Trimarco, V.; De Luca, N.; Trimarco, B. Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia. J. Hypertens., 2010, 28, 1482-1487.
    • (2010) J. Hypertens. , vol.28 , pp. 1482-1487
    • Izzo, R.1    De Simone, G.2    Giudice, R.3    Chinali, M.4    Trimarco, V.5    De Luca, N.6    Trimarco, B.7
  • 250
    • 77956589652 scopus 로고    scopus 로고
    • Berberine: A potential phytochemical with multispectrum therapeutic activities
    • Vuddanda, P.R.; Chakraborty, S.; Singh, S. Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opin. Investig. Drugs, 2010, 19, 1297-1307.
    • (2010) Expert Opin. Investig. Drugs , vol.19 , pp. 1297-1307
    • Vuddanda, P.R.1    Chakraborty, S.2    Singh, S.3
  • 251
    • 79958040988 scopus 로고    scopus 로고
    • Berberine acutely activates the glucose transport activity of GLUT1
    • Cok, A.; Plaisier, C.; Salie, M.J.; Oram, D.S.; Chenge, J.; Louters, L.L. Berberine acutely activates the glucose transport activity of GLUT1. Biochimie, 2011, 93, 1187-1192.
    • (2011) Biochimie , vol.93 , pp. 1187-1192
    • Cok, A.1    Plaisier, C.2    Salie, M.J.3    Oram, D.S.4    Chenge, J.5    Louters, L.L.6
  • 252
    • 77954214500 scopus 로고    scopus 로고
    • Berberine inhibits PTP1B activity and mimics insulin action
    • Chen, C.; Zhang, Y.; Huang, C. Berberine inhibits PTP1B activity and mimics insulin action. Biochem. Biophys. Res. Commun., 2010, 397, 543-547.
    • (2010) Biochem. Biophys. Res. Commun. , vol.397 , pp. 543-547
    • Chen, C.1    Zhang, Y.2    Huang, C.3
  • 253
    • 79959964544 scopus 로고    scopus 로고
    • Modulating gut microbiota as an anti-diabetic mechanism of berberine
    • Han, J.; Lin, H.; Huang, W. Modulating gut microbiota as an anti-diabetic mechanism of berberine. Med. Sci. Monit., 2011, 17, RA164-167.
    • (2011) Med. Sci. Monit. , vol.17
    • Han, J.1    Lin, H.2    Huang, W.3
  • 254
    • 77349115762 scopus 로고    scopus 로고
    • Berberine:: A plant alkaloid with therapeutic potential for central nervous system disorders
    • Kulkarni, S.K.; Dhir, A. Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother. Res., 2010, 24, 317-324.
    • (2010) Phytother. Res. , vol.24 , pp. 317-324
    • Kulkarni, S.K.1    Dhir, A.2
  • 255
    • 80054777175 scopus 로고    scopus 로고
    • The therapeutic potential of Berberis darwinii stem-bark: Quantification of berberine and in vitro evidence for Alzheimer's disease therapy
    • Habtemariam, S. The therapeutic potential of Berberis darwinii stem-bark: quantification of berberine and in vitro evidence for Alzheimer's disease therapy. Nat. Prod. Commun., 2011, 6, 1089-1090.
    • (2011) Nat. Prod. Commun. , vol.6 , pp. 1089-1090
    • Habtemariam, S.1
  • 256
    • 79960135910 scopus 로고    scopus 로고
    • In vivo and in vitro antiviral effects of berberine on influenza virus
    • Wu, Y.; Li, J.Q.; Kim, Y.J.; Wu, J.; Wang, Q.; Hao, Y. In vivo and in vitro antiviral effects of berberine on influenza virus. Chin. J. Integr. Med., 2011, 17, 444-452.
    • (2011) Chin. J. Integr. Med. , vol.17 , pp. 444-452
    • Wu, Y.1    Li, J.Q.2    Kim, Y.J.3    Wu, J.4    Wang, Q.5    Hao, Y.6
  • 257
    • 84860523753 scopus 로고    scopus 로고
    • Vasodilatation produced by Fasudil Mesylate in vivo and in vitro
    • Li, Q.; Chen, Y.; Sun, L.; Fu, G.; Guo, L. Vasodilatation produced by Fasudil Mesylate in vivo and in vitro. Vascul. Pharmacol., 2011, 55, 121-126.
    • (2011) Vascul. Pharmacol. , vol.55 , pp. 121-126
    • Li, Q.1    Chen, Y.2    Sun, L.3    Fu, G.4    Guo, L.5
  • 259
    • 79960792540 scopus 로고    scopus 로고
    • Recent progress in the management of pulmonary hypertension
    • Fukumoto, Y.; Shimokawa, H. Recent progress in the management of pulmonary hypertension. Circ. J., 2011, 75, 1801-1810.
    • (2011) Circ. J. , vol.75 , pp. 1801-1810
    • Fukumoto, Y.1    Shimokawa, H.2
  • 261
    • 0040029094 scopus 로고    scopus 로고
    • Raynaud's phenomenon
    • O'Connor, C.M. Raynaud's phenomenon. J. Vasc. Nurs., 2001, 19, 87-92.
    • (2001) J. Vasc. Nurs. , vol.19 , pp. 87-92
    • O'connor, C.M.1
  • 263
    • 33644794902 scopus 로고    scopus 로고
    • Cardioprotective effect of hydroxyfasudil as a specific Rho-kinase inhibitor, on ischemia-reperfusion injury in canine coronary microvessels in vivo
    • Yada, T.; Shimokawa, H.; Kajiya, F. Cardioprotective effect of hydroxyfasudil as a specific Rho-kinase inhibitor, on ischemia-reperfusion injury in canine coronary microvessels in vivo. Clin. Hemorheol. Microcirc., 2006, 34, 177-183. (Pubitemid 43351027)
    • (2006) Clinical Hemorheology and Microcirculation , vol.34 , Issue.1-2 , pp. 177-183
    • Yada, T.1    Shimokawa, H.2    Kajiya, F.3
  • 265
    • 84855837715 scopus 로고    scopus 로고
    • Sotrastaurin: A new selective protein kinase C inhibitor, on the way
    • Yamashita, K.; Todo, S. Sotrastaurin, a new selective protein kinase C inhibitor, on the way. Transplantation, 2011, 93, 146-147.
    • (2011) Transplantation , vol.93 , pp. 146-147
    • Yamashita, K.1    Todo, S.2
  • 274
    • 77955094938 scopus 로고    scopus 로고
    • Phase II study of Cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (National Cancer Institute #7097)
    • Ramalingam, S.S.; Belani, C.P.; Mack, P.C.; Vokes, E.E.; Longmate, J.; Govindan, R.; Koczywas, M.; Ivy, S.P.; Gandara, D.R. Phase II study of Cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (National Cancer Institute #7097). J. Thorac. Oncol., 2010, 5, 1279-1284.
    • (2010) J. Thorac. Oncol. , vol.5 , pp. 1279-1284
    • Ramalingam, S.S.1    Belani, C.P.2    MacK, P.C.3    Vokes, E.E.4    Longmate, J.5    Govindan, R.6    Koczywas, M.7    Ivy, S.P.8    Gandara, D.R.9
  • 277
    • 84856509572 scopus 로고    scopus 로고
    • Phase i study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours
    • Dean, E.; Middleton, M.R.; Pwint, T.; Swaisland, H.; Carmichael, J.; Goodege-Kunwar, P.; Ranson, M. Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours. Br. J. Cancer, 2012, 106, 468-474.
    • (2012) Br. J. Cancer , vol.106 , pp. 468-474
    • Dean, E.1    Middleton, M.R.2    Pwint, T.3    Swaisland, H.4    Carmichael, J.5    Goodege-Kunwar, P.6    Ranson, M.7
  • 278
    • 80054869232 scopus 로고    scopus 로고
    • PARP inhibitors-current status and the walk towards early breast cancer
    • Glendenning, J.; Tutt, A. PARP inhibitors-current status and the walk towards early breast cancer. Breast., 2011, 20 Suppl 3, S12-19.
    • (2011) Breast. , vol.20 SUPPL. 3
    • Glendenning, J.1    Tutt, A.2
  • 279
    • 0033198919 scopus 로고    scopus 로고
    • Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
    • DOI 10.1042/0264-6021:3420249
    • D'Amours, D.; Desnoyers, S.; D'Silva, I.; Poirier, G.G. Poly(ADPribosyl) ation reactions in the regulation of nuclear functions. Biochem. J., 1999, 342, 249-268. (Pubitemid 29425344)
    • (1999) Biochemical Journal , vol.342 , Issue.2 , pp. 249-268
    • D'Amours, D.1    Desnoyers, S.2    D'Silva, I.3    Poirier, G.G.4
  • 280
    • 0032842477 scopus 로고    scopus 로고
    • Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability
    • DOI 10.1038/12680
    • d'Adda di Fagagna, F.; Hande, M.P.; Tong, W.M.; Lansdorp, P.M.; Wang, Z.Q.; Jackson, S.P. Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability. Nat. Genet., 1999, 23, 76-80. (Pubitemid 29418792)
    • (1999) Nature Genetics , vol.23 , Issue.1 , pp. 76-80
    • Di Fagagna, F.D.1    Hande, M.P.2    Tong, W.-M.3    Lansdorp, P.M.4    Wang, Z.-Q.5    Jackson, S.P.6
  • 281
    • 4544374528 scopus 로고    scopus 로고
    • BRCA1 and BRCA2: 1994 and beyond
    • DOI 10.1038/nrc1431
    • Narod, S.A.; Foulkes, W.D. BRCA1 and BRCA2: 1994 and beyond. Nat. Rev. Cancer, 2004, 4, 665-676. (Pubitemid 39215065)
    • (2004) Nature Reviews Cancer , vol.4 , Issue.9 , pp. 665-676
    • Narod, S.A.1    Foulkes, W.D.2
  • 282
    • 77951445939 scopus 로고    scopus 로고
    • Poly(adp-ribose) polymerase inhibitors: A novel drug class with a promising future
    • Gartner, E.M.; Burger, A.M.; Lorusso, P.M. Poly(adp-ribose) polymerase inhibitors: a novel drug class with a promising future. Cancer J., 2010, 16, 83-90.
    • (2010) Cancer J. , vol.16 , pp. 83-90
    • Gartner, E.M.1    Burger, A.M.2    Lorusso, P.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.